{
  "meta": {
    "title": "00057_Late_Night_Pyq_Pyt_Marathon_-_57",
    "url": "https://brainandscalpel.vercel.app/00057-late-night-pyq-pyt-marathon-57-759c6d01.html",
    "scrapedAt": "2025-11-29T17:25:03.147Z"
  },
  "questions": [
    {
      "id": 10349,
      "choices": [
        {
          "id": 41362,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        },
        {
          "id": 41363,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriasis</span></p>"
        },
        {
          "id": 41364,
          "text": "<p><span style=\"font-size:12.0pt;\">Post traumatic pigmentation</span></p>"
        },
        {
          "id": 41365,
          "text": "<p><span style=\"font-size:12.0pt;\">Atopic dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with complaints of itching and discharges on flexure aspect of elbow and the lesions were red as shown below. What is your diagnosis? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-101712.png\" alt=\"\" width=\"300\" height=\"255\"></p>",
      "unique_key": "Q7500629",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618483,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Atopic dermatitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most likely diagnosis for the case presented is <strong>atopic dermatitis</strong>, a common inflammatory skin condition often associated with the atopic state, which includes eczema, asthma, and allergic rhinitis. This condition is characterized by impaired epidermal barrier function, often due to a genetic predisposition. In many patients, a mutation in the <i>filaggrin</i> gene is responsible for this barrier defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Atopic dermatitis</strong> typically presents with:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Eczematous lesions</strong>: These lesions are often red, inflamed, and may ooze or become crusted. They frequently occur in flexural areas such as the elbows, knees, and neck.</span></li><li><span style=\"font-size:12pt;\"><strong>Pruritus (itching)</strong>: Intense itching is a hallmark of atopic dermatitis, often leading to scratching that can exacerbate the lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Chronic course</strong>: The condition usually has a chronic course with periods of exacerbation and remission. Lesions often persist for more than 6 weeks.</span></li><li><span style=\"font-size:12pt;\"><strong>Family history</strong>: There is often a personal or family history of atopic conditions, including asthma, allergic rhinitis, or food allergies.</span></li><li><span style=\"font-size:12pt;\"><strong>Lichenification</strong>: Chronic scratching may lead to thickened, leathery skin, known as lichenification.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical image provided shows red, excoriated lesions in the flexure aspect of the elbow, which is highly characteristic of atopic dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pemphigus vulgaris:</strong> This is an autoimmune blistering disorder that typically presents with flaccid blisters and erosions on the skin and mucous membranes, not with the eczematous lesions seen in atopic dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Psoriasis:</strong> Psoriasis typically presents with well-demarcated, thick, silvery scales on extensor surfaces like the elbows and knees. It is not associated with the flexural distribution or the intense pruritus seen in atopic dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Post-traumatic pigmentation:</strong> This refers to skin discoloration following an injury. It does not present with eczematous lesions or intense itching, and it is not limited to flexural areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Atopic dermatitis typically presents with pruritic, eczematous lesions on flexural areas, often associated with a personal or family history of atopy.</span></p>",
      "correct_choice_id": 41365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20335,
      "choices": [
        {
          "id": 81301,
          "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 10-20 mL/kg and start insulin after 1 hour</span></p>"
        },
        {
          "id": 81302,
          "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 20 mL/kg along with insulin 0.1 IU/kg/hr</span></p>"
        },
        {
          "id": 81303,
          "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 10 mL/kg along with insulin 0.1 IU/kg/hr</span></p>"
        },
        {
          "id": 81304,
          "text": "<p><span style=\"font-size:12pt;\">Manage ABC, NS 30 mL/kg and start insulin after 1 hour</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 8-year-old child weighing 26 kg presents with a history of loose stools for 2 days. On examination, there is severe dehydration. Laboratory investigations are as follows. What is the initial management as per ISPAD guidelines? (NEET PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\">RBS → 550</span></p><p><span style=\"font-size:12pt;\">рН → 7.01</span></p><p><span style=\"font-size:12pt;\">Na+ → 158</span></p><p><span style=\"font-size:12pt;\">Urine glucose → 3+</span></p><p><span style=\"font-size:12.0pt;\">Urine Ketone → +ve</span></p>",
      "unique_key": "Q8668116",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Manage ABC, NS 10-20 mL/kg and start insulin after 1 hour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given clinical scenario points to diagnosis of diabetic ketoacidosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">According to the ISPAD guidelines shown below, first the patient has to be classified for shock/Moderate dehydration/minimal dehydration. In this given scenario, child is in shock, so, the initial management includes management of the airway, breathing, and circulation (ABC) and fluid replacement along with an IV bolus of 20 mL/kg 0.9% Normal saline, followed by an IV insulin infusion of 0.05 - 0.1 U/kg/hr, 1 hour after starting fluid replacement therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/doc18.jpg\" alt=\"\" width=\"879\" height=\"1256\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Manage ABC, NS 20 mL/kg along with insulin 0.1 IU/kg/hr.:&nbsp;</strong>First we will give fluids and then after one hour we will give insulin</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. Manage ABC, NS 10 mL/kg along with insulin 0.1 IU/kg/hr:</strong> The fluid volume of 10 mL/kg is insufficient for severe dehydration and shock. The correct volume is 20 mL/kg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. Manage ABC, NS 30 mL/kg and start insulin after 1 hour:</strong> This option provides an insufficient fluid volume and delays insulin administration, which is not recommended in severe cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of diabetic ketoacidosis (DKA) in children, the initial treatment includes managing ABC, administering 20 mL/kg of 0.9% normal saline, and starting an insulin infusion at 0.1 U/kg/hr.</span></p>",
      "correct_choice_id": 81301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54648,
      "choices": [
        {
          "id": 218057,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute malnutrition</span></p>"
        },
        {
          "id": 218058,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic malnutrition</span></p>"
        },
        {
          "id": 218059,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute on chronic malnutrition</span></p>"
        },
        {
          "id": 218060,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child with weight for height less than minus 1 SD &amp; height for age is minus 2 SD. What is the best possible assessment?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3864146",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618485,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chronic malnutrition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic malnutrition, also known as stunting, is indicated by a height for age that is significantly below the normal. According to World Health Organization (WHO) standards, a height for age that is less than minus 2 standard deviations (SD) from the median of the reference population is indicative of stunting. In this question, the child has a height for age of minus 2 SD, which points to chronic malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Acute malnutrition:</strong> This is typically indicated by a significant weight loss over a short period, reflected in weight for height measurements. A weight for height less than minus 3 SD from the median would indicate severe acute malnutrition, but in this case, the weight for height is less than minus 1 SD, which is not sufficient to diagnose acute malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Acute on chronic malnutrition:</strong> This would be indicated if the child had signs of both chronic malnutrition (height for age less than minus 2 SD) and significant recent weight loss. However, the weight for height is only less than minus 1 SD, not indicative of acute malnutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>None of the above:</strong> This is incorrect as chronic malnutrition is clearly indicated by the height for age of minus 2 SD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic malnutrition is diagnosed when a child's height for age is less than minus 2 standard deviations from the median of the reference population, indicating stunting.</span></p>",
      "correct_choice_id": 218058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10263,
      "choices": [
        {
          "id": 41018,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 41019,
          "text": "<p><span style=\"font-size:12.0pt;\">CSF</span></p>"
        },
        {
          "id": 41020,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood</span></p>"
        },
        {
          "id": 41021,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A baby in the NICU is being evaluated for his features of microcephaly and hepatomegaly. CT scan revealed nodular periventricular calcifications. Congenital CMV infection is suspected. Which of the following samples is the best to detect the organism using PCR? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7769205",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618486,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Urine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Urine is the best sample</strong> to send for the diagnosis of congenital cytomegalovirus infection among the following options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV can be detected using <strong>either PCR or culture</strong>. <u>Saliva, urine, or blood can be used </u>to collect the sample.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Intrauterine growth retardation (IUGR)</span></li><li><span style=\"font-size:12.0pt;\">Prematurity</span></li><li><span style=\"font-size:12.0pt;\">Microcephaly</span></li><li><span style=\"font-size:12.0pt;\">Intracranial calcifications (Periventricular)</span></li><li><span style=\"font-size:12.0pt;\">Chorioretinitis</span></li><li><span style=\"font-size:12.0pt;\">Sensorineural hearing loss (SNHL)</span></li><li><span style=\"font-size:12.0pt;\">Hepatosplenomegaly</span></li><li><span style=\"font-size:12.0pt;\">Jaundice</span></li><li><span style=\"font-size:12.0pt;\">Blueberry-muffin-like rash</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia, purpura</span></li><li><span style=\"font-size:12.0pt;\">Mild increases in CSF protein</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2_v6gG1Oj.jpg\" alt=\"\" width=\"300\" height=\"361\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Liver biopsy:</strong> In any of the TORCH infection, liver biopsy is not the investigation of choice. Live biopsy is the gold standard investigation of choice in Wilson disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CSF</strong>: In case of suspected meningitis we do CSF, not in TORCH profile</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Blood</strong>: In this question blood sample is not the right option. If the question was regarding diagnosing of congenital varicella infection, then the right choice would be ANTI – VZV – ANTIBODY</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Urine is the most appropriate sample for the detection of congenital cytomegalovirus (CMV) infection using PCR, particularly in the neonatal period.</span></p>",
      "correct_choice_id": 41021,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10165,
      "choices": [
        {
          "id": 40626,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 40627,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocorticotropic hormone (ACTH)</span></p>"
        },
        {
          "id": 40628,
          "text": "<p><span style=\"font-size:12.0pt;\">Levetiracetam</span></p>"
        },
        {
          "id": 40629,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenobarbitone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-month-old infant was brought with complaints of jerking movement of limbs towards the body. On examination, there is a regression of developmental milestones. Electroencephalogram shows hypsarrhythmia. Which of the following is the drug of choice in this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q8021408",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618487,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Adrenocorticotropic hormone (ACTH)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and EEG findings are consistent with infantile spasms, which is seen in WEST Syndrome. The drug of choice for treating infantile spasms in WEST syndrome is adrenocorticotropic hormone (ACTH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drug of choice of baby with infantile spasms in tuberous sclerosis is vigabtrin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infantile spasms typically present as clusters of sudden, brief, symmetric, and often flexor or extensor jerks of the limbs or trunk. The spasms are usually associated with regression of developmental milestones, including loss of acquired skills such as smiling, babbling, or sitting up. Hypsarrhythmia, which is a chaotic and disorganized pattern of high-amplitude, asynchronous spikes and slow waves on EEG, is a characteristic finding in infantile spasms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ACTH is the most effective medication for the treatment of infantile spasms. It is believed to work by decreasing the inflammation and abnormal electrical activity in the brain that is thought to be responsible for the spasms. ACTH is typically administered as a daily injection, usually for a duration of several weeks. The response to treatment is usually monitored with serial EEGs, which should show improvement in the hypsarrhythmia pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">West syndrome is severe generalized epilepsy that begins between the ages of 2 and 12 months. It is characterized by a triad of:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Infantile epileptic spasms</span></li><li><span style=\"font-size:12.0pt;\">Developmental regression</span></li><li><span style=\"font-size:12.0pt;\">Hypsarrhythmia on electroencephalogram (EEG)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypsarrhythmia refers to a high voltage, slow, chaotic background with multifocal spikes</span></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/6_budhxHY.jpg\" alt=\"\" width=\"289\" height=\"289\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenytoin:&nbsp;</strong>Phenytoin is the second line of drug of choice in neonatal seizures but is not typically used for treating infantile spasms associated with West Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Levetiracetam:&nbsp;</strong>Levetiracetam is an antiepileptic medication but is not the first-line treatment for West Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenobarbitone:&nbsp;</strong>Phenobarbitone is the first line of drug of choice in neonatal seizures but is not the preferred treatment for infantile spasms in West Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adrenocorticotropic hormone (ACTH) is the drug of choice for treating infantile spasms in West Syndrome.</span></p>",
      "correct_choice_id": 40627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61371,
      "choices": [
        {
          "id": 244761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ferrous sulfate</span></span></span></p>"
        },
        {
          "id": 244762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Isotretinoin </span></span></span></p>"
        },
        {
          "id": 244763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folic acid&nbsp; </span></span></span></p>"
        },
        {
          "id": 244764,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoclopramide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following medications taken during pregnancy is associated with the birth defect shown in the image?</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> (AIIMS NOV 2016)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/picture1_3iGG9g0.jpg\" style=\"height:370px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8098467",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618488,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. Isotretinoin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The facial defects, including cleft lip, observed in the child are characteristic of the teratogenic effects of isotretinoin. Isotretinoin is commonly used to treat severe acne but is highly teratogenic and should never be prescribed to women of reproductive age without ensuring they are not pregnant. The teratogenic effects of isotretinoin include craniofacial, cardiovascular, thymic, and central nervous system abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Ferrous sulfate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This is an iron supplement and does not cause such birth defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Folic acid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This vitamin is actually recommended during pregnancy to prevent birth defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Metoclopramide</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This antiemetic is not associated with the type of birth defects described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Isotretinoin, used for severe acne treatment, is highly teratogenic and associated with severe birth defects such as craniofacial abnormalities, including cleft lip and palate.</span></span></span></p>",
      "correct_choice_id": 244762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23236,
      "choices": [
        {
          "id": 92908,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 92909,
          "text": "<p><span style=\"font-size:12.0pt;\">IVIG</span></p>"
        },
        {
          "id": 92910,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 92911,
          "text": "<p><span style=\"font-size:12.0pt;\">LMWH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old male child arrived with a history of fever, reddened and congested conjunctiva, along with skin exhibiting redness and peeling, as depicted in the provided images. A 2D echocardiogram revealed the presence of a coronary aneurysm. What constitutes the initial course of treatment for this condition? (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_53.jpg\" alt=\"\" width=\"400\" height=\"359\"></span></p>",
      "unique_key": "Q7543932",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618489,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) IVIG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical presentation of fever, congested conjunctiva, strawberry tongue, and red skin peeling, along with the echocardiogram finding of a coronary aneurysm, is highly suggestive of <strong>Kawasaki disease</strong>. Kawasaki disease is a systemic vasculitis that primarily affects children and can lead to coronary artery aneurysms if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Initial Treatment:&nbsp;</strong>The mainstay of treatment for Kawasaki disease is the administration of <strong>Intravenous Immunoglobulin (IVIG)</strong>. IVIG is given to reduce the risk of coronary artery aneurysms, which is the most serious complication of Kawasaki disease. The standard dose is 2 g/kg administered as a single infusion, usually within the first 10 days of illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aspirin:</strong> Aspirin is also used in the management of Kawasaki disease, typically in conjunction with IVIG. However, IVIG is the first-line treatment to reduce inflammation and prevent coronary complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Clopidogrel:</strong> Clopidogrel is an antiplatelet agent, but it is not part of the initial treatment for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. LMWH:</strong> Low Molecular Weight Heparin (LMWH) is an anticoagulant, but it is not used as the primary treatment for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">In Kawasaki disease, the initial course of treatment involves the administration of IVIG to reduce the risk of coronary artery aneurysms and other complications.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-151928.png\" alt=\"\" width=\"1000\" height=\"568\"></p>",
      "correct_choice_id": 92909,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10270,
      "choices": [
        {
          "id": 41046,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 24 hours after starting antibiotics</span></p>"
        },
        {
          "id": 41047,
          "text": "<p><span style=\"font-size:12.0pt;\">Till cultures become negative</span></p>"
        },
        {
          "id": 41048,
          "text": "<p><span style=\"font-size:12.0pt;\">Till antibiotic course is complete</span></p>"
        },
        {
          "id": 41049,
          "text": "<p><span style=\"font-size:12.0pt;\">Till 12 hours after admission</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How long should a child be isolated after being diagnosed with bacterial meningitis to prevent further transmission? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q2844855",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618490,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Till 24 hours after starting antibiotics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended duration for isolation in cases of bacterial meningitis is <strong>until 24 hours after the initiation of effective antibiotic therapy</strong>. This is crucial for preventing the spread of infections caused by organisms such as <strong>Neisseria meningitidis</strong> and <strong>Haemophilus influenzae type b (Hib)</strong>. After 24 hours of effective treatment, the risk of transmission significantly decreases, allowing the patient to be removed from isolation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Guidelines for prophylaxis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Standard precautions&nbsp;</strong>should be implemented for all patients admitted with meningitis.</span></li><li><span style=\"font-size:12.0pt;\">Patients with <strong>Neisseria meningitidis</strong> and <strong>Hib meningitis</strong> should be placed on <strong>droplet precautions</strong> until they have received 24 hours of effective antibiotic therapy.</span></li><li><span style=\"font-size:12.0pt;\">Patients with these infections should be placed in <strong>private rooms</strong> during this isolation period.</span></li><li><span style=\"font-size:12.0pt;\">Hospital personnel should wear a <strong>face mask</strong> when within 3 feet (1 meter) of the patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Till cultures become negative:&nbsp;</strong>This is not a practical or recommended criterion for lifting isolation because cultures can take several days to become negative, and the patient is not typically contagious after 24 hours of effective treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Till antibiotic course is complete:&nbsp;</strong>The full course of antibiotics may last 7-14 days, during which time isolation is not necessary after the first 24 hours of effective treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Till 12 hours after admission:&nbsp;</strong>This is incorrect as it does not meet the standard infection control guidelines. The 24-hour mark after starting effective antibiotics is the critical time point for lifting isolation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Children with bacterial meningitis caused by Neisseria meningitidis or Haemophilus influenzae should be isolated for 24 hours after starting effective antibiotic therapy to prevent transmission.</span></p>",
      "correct_choice_id": 41046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33325,
      "choices": [
        {
          "id": 133146,
          "text": "<p><span style=\"font-size:12.0pt;\">ABO incompatibility</span></p>"
        },
        {
          "id": 133147,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive cardiac failure</span></p>"
        },
        {
          "id": 133148,
          "text": "<p><span style=\"font-size:12.0pt;\">Parvovirus infection</span></p>"
        },
        {
          "id": 133149,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosomal anomalies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Causes of non-immune hydrops fetalis are all except: (INICET NOV 2023)</span></p>",
      "unique_key": "Q2460981",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618491,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) ABO incompatibility</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ABO incompatibility is an immune-mediated cause of hemolytic disease of the newborn, but it is not typically associated with non-immune hydrops fetalis. Non-immune hydrops is often caused by factors other than immune reactions, such as congenital heart defects, infections, or chromosomal anomalies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Congestive cardiac failure: </strong>Congestive cardiac failure can contribute to non-immune hydrops fetalis. Conditions affecting the fetal heart can lead to fluid accumulation, resulting in hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Parvovirus infection: </strong>Parvovirus infection is a known cause of non-immune hydrops fetalis. Parvovirus can affect the developing fetus and lead to severe anemia, causing fluid accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Chromosomal anomalies: </strong>Chromosomal anomalies, such as Turner syndrome or trisomy 21, are associated with non-immune hydrops fetalis. Abnormalities in fetal development, including those affecting multiple organ systems, can lead to fluid accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the various causes of non-immune hydrops fetalis. Understand that conditions such as congestive cardiac failure, infections (e.g., parvovirus), and chromosomal anomalies can contribute to the development of hydrops in the absence of immune-mediated factors. Be aware that ABO incompatibility is not a typical cause of non-immune hydrops fetalis.</span></p>",
      "correct_choice_id": 133146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10307,
      "choices": [
        {
          "id": 41194,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 41195,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure to thrive</span></p>"
        },
        {
          "id": 41196,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrythmia</span></p>"
        },
        {
          "id": 41197,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Surgical correction of VSD is performed in an infant. This will help in relieving which of the following features? </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p>",
      "unique_key": "Q6238904",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618492,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Failure to thrive.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Surgical correction of a Ventricular Septal Defect (VSD) primarily helps in relieving the symptoms of congestive heart failure, which often manifest as failure to thrive in infants. Infants with VSD may experience poor weight gain, difficulty feeding, excessive sweating, irritability, and signs of respiratory distress such as tachypnea and labored breathing. These symptoms arise because the left-to-right shunt created by the VSD increases pulmonary blood flow, leading to pulmonary overcirculation and congestive heart failure. Surgical intervention closes the defect, thereby normalizing blood flow and alleviating the symptoms of heart failure, allowing the infant to grow and thrive normally.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The key indications for VSD surgery include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Large defects associated with pulmonary hypertension.</span></li><li><span style=\"font-size:12.0pt;\">Qp ratio greater than 2:1 (indicating a significant left-to-right shunt).</span></li><li><span style=\"font-size:12.0pt;\">Supracristal VSD, which carries a risk of aortic valve involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Respiratory alkalosis</strong>: Respiratory alkalosis is not typically associated with VSD. VSD primarily affects the heart and pulmonary circulation rather than directly causing changes in the acid-base balance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Arrhythmia</strong>: Arrhythmias in infants are usually related to electrolyte imbalances or other cardiac conditions, but not directly to VSD. Surgical correction of VSD is aimed at correcting the structural defect, not managing arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Heart block</strong>: Heart block is a conduction issue in the heart and is not a feature directly caused by VSD. VSD surgery does not specifically address heart block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Surgical correction of VSD in infants primarily helps relieve congestive heart failure symptoms, particularly failure to thrive, by normalizing pulmonary blood flow.</span></p>",
      "correct_choice_id": 41195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61377,
      "choices": [
        {
          "id": 244785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tetralogy of Fallot</span></span></span></p>"
        },
        {
          "id": 244786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transposition of the Great Arteries</span></span></span></p>"
        },
        {
          "id": 244787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total Anomalous Pulmonary Venous Connection (TAPVC)</span></span></span></p>"
        },
        {
          "id": 244788,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular Septal Defect (VSD)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 2-week-old infant presents with cyanosis, respiratory distress, and poor feeding. On physical examination, the infant shows signs of tachypnea and tachycardia. An echocardiogram is performed, which reveals abnormal venous return of the pulmonary veins, with no direct connection to the left atrium. Further evaluation indicates equal oxygen saturation in all four chambers of the heart. Which of the following congenital heart diseases is most likely responsible for this finding?</span></span></span></p>",
      "unique_key": "Q4634622",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618493,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: C) Total Anomalous Pulmonary Venous Connection (TAPVC)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total Anomalous Pulmonary Venous Connection (TAPVC) is a congenital heart defect in which the pulmonary veins do not connect normally to the left atrium. Instead, oxygenated blood from the lungs is redirected to the right atrium via connections to the superior vena cava, inferior vena cava, or both. This leads to a total mixing lesion where both oxygenated and deoxygenated blood mix completely, resulting in equal oxygen saturation in all four heart chambers. Blood reaches the left atrium and subsequently the left ventricle only through an atrial septal defect (ASD) or a patent foramen ovale, which shunts the mixed blood from the right atrium. This unique feature of TAPVC results in the characteristic finding of equal oxygen saturation in all cardiac chambers. TAPVC often presents with cyanosis, respiratory distress, and poor feeding in neonates and requires urgent surgical correction to restore normal pulmonary venous return.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/picture6.jpg\" style=\"height:266px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Tetralogy of Fallot:</strong> This defect involves right ventricular outflow obstruction, a ventricular septal defect, overriding aorta, and right ventricular hypertrophy. It results in cyanosis due to right-to-left shunting but does not cause equal saturation in all chambers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B) Transposition of the Great Arteries:</strong> This condition features parallel circulations with the aorta arising from the right ventricle and the pulmonary artery from the left ventricle, leading to severe cyanosis without equal saturation across all chambers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D) Ventricular Septal Defect (VSD):</strong> A VSD allows for shunting of blood between the ventricles, but it does not cause equal oxygen saturation in all heart chambers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TAPVC is a congenital heart defect that leads to equal oxygen saturation in all heart chambers due to the abnormal drainage of pulmonary veins into the right atrium, causing complete mixing of oxygenated and deoxygenated blood. Early diagnosis and surgical intervention are crucial to reestablish normal pulmonary venous return and prevent complications.</span></span></span></p>",
      "correct_choice_id": 244787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9956,
      "choices": [
        {
          "id": 39790,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweat chloride test chloride conc of 70 mEg/L</span></p>"
        },
        {
          "id": 39791,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase immunoreactive trypsinogen level</span></p>"
        },
        {
          "id": 39792,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 39793,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraction alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not seen in a child with cystic fibrosis? (NEET PG 2019)</span></p>",
      "unique_key": "Q2120437",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618554,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hyperkalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cystic fibrosis (CF) is a genetic disorder that affects multiple systems, primarily the respiratory and digestive systems, due to a defect in the CFTR gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is not typically seen in cystic fibrosis. Instead, CF patients are more likely to experience hypokalemia due to the loss of electrolytes through sweat and the effects of contraction alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis and features of cystic fibrosis include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Sweat chloride test chloride concentration of 70 mEq/L:&nbsp;</strong>The sweat chloride test is the gold standard for diagnosing CF. A chloride concentration greater than 60 mEq/L is indicative of CF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increased immunoreactive trypsinogen level:&nbsp;</strong>Newborn screening for CF often includes measuring immunoreactive trypsinogen levels, which are elevated in CF patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Contraction alkalosis:&nbsp;</strong>CF patients can present with contraction alkalosis due to loss of water and sodium, and renal waste of potassium and hydrogen ions. This is similar to the effects seen in patients taking loop diuretics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hyperkalemia is not typically seen in cystic fibrosis. Instead, patients with CF may present with hypokalemia and contraction alkalosis due to electrolyte losses.</span></p>",
      "correct_choice_id": 39792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10335,
      "choices": [
        {
          "id": 41306,
          "text": "<p><span style=\"font-size:12.0pt;\">33 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41307,
          "text": "<p><span style=\"font-size:12.0pt;\">40 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41308,
          "text": "<p><span style=\"font-size:12.0pt;\">55 ml/min/1.73 m2 BSA</span></p>"
        },
        {
          "id": 41309,
          "text": "<p><span style=\"font-size:12.0pt;\">80 ml/min/1.73 m2 BSA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old male child with a body weight of 15kg and height of 100cm is admitted with renal failure. His blood urea was 100 mg/dL and serum creatinine was 1 mg/dL. What is the closest calculated eGFR in the patient? (INICET MAY 2022)</span></p>",
      "unique_key": "Q2150515",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618555,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 40 ml/min/1.73 m2 BSA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step-by-Step Calculation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 1: Identify the appropriate k value</strong></span></p><p><span style=\"font-size:12.0pt;\">For a 4-year-old child: k = 0.413</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 2: Apply the formula</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = k × Height / Serum Creatinine</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 3: Substitute values</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = 0.413 × 100 / 1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 4: Calculate</strong></span></p><p><span style=\"font-size:12.0pt;\">eGFR = 41.3 / 1 = 41.3 ml/min/1.73 m²</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 5: Round to nearest option</strong></span></p><p><span style=\"font-size:12.0pt;\">41.3 ≈ 40 ml/min/1.73 m² BSA</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The estimated Glomerular Filtration Rate (eGFR) in pediatric patients can be calculated using the Schwartz formula, which is widely used in clinical practice. The formula takes into account the patient's height and serum creatinine levels, along with a constant value that is adjusted for age and sex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The modified Schwartz formula is most commonly used for this purpose. It is given as:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-095909.png\" alt=\"\" width=\"400\" height=\"81\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For children aged 1 to 16 years, the constant k is typically 0.413</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the child's height of 100 cm and serum creatinine of 1 mg/dL:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-095949.png\" alt=\"\" width=\"500\" height=\"48\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The closest value provided in the options is 40 ml/min/1.73 m² BSA, which is therefore the correct answer</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand and apply the Schwartz formula for estimating eGFR in pediatric patients based on height and serum creatinine levels.</span></p>",
      "correct_choice_id": 41307,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10358,
      "choices": [
        {
          "id": 41398,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurler disease</span></p>"
        },
        {
          "id": 41399,
          "text": "<p><span style=\"font-size:12.0pt;\">Beckwith-Wiedemann syndrome</span></p>"
        },
        {
          "id": 41400,
          "text": "<p><span style=\"font-size:12.0pt;\">Proteus Syndrome</span></p>"
        },
        {
          "id": 41401,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male child with coarse facies, macroglossia, thick lips with hepatosplenomegaly presents with copious mucous discharge from the nose. The most probable underlying diagnosis is? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q2184829",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hurler disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation described, including coarse facial features, macroglossia (enlarged tongue), thick lips, hepatosplenomegaly (enlargement of the liver and spleen), and copious mucus discharge from the nose, is characteristic of <strong>Hurler disease</strong>. Hurler disease is a severe form of mucopolysaccharidosis type 1 (MPS 1), which results from a deficiency in the enzyme alpha-L-iduronidase. This deficiency leads to the accumulation of glycosaminoglycans, specifically heparan sulfate and dermatan sulfate, in various tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Clinical Features of Hurler Disease:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Coarse facial features:</strong> The facial appearance is often described as \"gargoyle-like\" due to the thickening of facial structures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Macroglossia and thick lips:</strong> Enlargement of the tongue and thickened lips are common in Hurler disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatosplenomegaly:</strong> Enlargement of the liver and spleen is a typical finding.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Corneal clouding:</strong> Although not mentioned in the question, this is another characteristic finding in Hurler disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Skeletal abnormalities:</strong> These include joint stiffness, short stature, and skeletal dysplasia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Upper respiratory tract involvement:</strong> Patients may experience recurrent respiratory infections, noisy breathing, and persistent nasal discharge.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Beckwith-Wiedemann syndrome:</strong> This is an overgrowth syndrome characterized by features such as macrosomia (large body size), macroglossia, hemihypertrophy (asymmetrical body growth), omphalocele (abdominal wall defect), and an increased risk of certain cancers like Wilms tumor and hepatoblastoma. However, the combination of features presented in this case aligns more closely with Hurler disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Proteus Syndrome:</strong> This is a rare condition characterized by overgrowth of bones, skin, and other tissues. It does not typically present with the features described in the question, such as coarse facies, hepatosplenomegaly, and copious mucus discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypothyroidism:</strong> While congenital hypothyroidism can present with macroglossia and coarse facial features, it typically does not cause the combination of symptoms described in this case, such as hepatosplenomegaly and persistent nasal discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hurler disease, a form of mucopolysaccharidosis type 1, presents with coarse facial features, macroglossia, hepatosplenomegaly, and copious nasal discharge, and is caused by a deficiency in alpha-L-iduronidase leading to the accumulation of glycosaminoglycans.</span></p>",
      "correct_choice_id": 41398,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10418,
      "choices": [
        {
          "id": 41638,
          "text": "<p>1, 2, 3, 4</p>"
        },
        {
          "id": 41639,
          "text": "<p>2, 1, 4, 3</p>"
        },
        {
          "id": 41640,
          "text": "<p>1, 3, 4, 2</p>"
        },
        {
          "id": 41641,
          "text": "<p>1, 2, 4, 3</p>"
        }
      ],
      "text": "<p>How would you manage a child with status epilepticus? (INICET NOV 2022)</p><p>&nbsp;</p><ol><li>Airway and breathing</li><li>IV Lorazepam</li><li>Midazolam, Propofol, Thiopentone</li><li>IV Fosphenytoin</li></ol>",
      "unique_key": "Q8166147",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><strong>Ans. D) 1, 2, 4, 3</strong></p><p>&nbsp;</p><p>Status epilepticus is defined as continuous or recurrent seizure activity lasting for more than 5 minutes without regaining consciousness.</p><p>&nbsp;</p><p><strong>Status epilepticus&nbsp;</strong>is a neurological emergency defined as continuous or recurrent seizure activity lasting for more than 5 minutes without regaining consciousness between episodes. Prompt and systematic management is essential to prevent long-term neurological damage or death.</p><p>&nbsp;</p><p><strong>Management Sequence:</strong></p><p>&nbsp;</p><p><strong>1. Airway and Breathing:&nbsp;</strong>The first priority is to ensure that the airway is open and that the child is breathing adequately. This may involve positioning the child, providing oxygen, and, if necessary, securing the airway with advanced airway management techniques.</p><p>&nbsp;</p><p><strong>2. IV Lorazepam:&nbsp;</strong>Benzodiazepines, such as lorazepam, are the first-line treatment for status epilepticus due to their rapid onset of action and effectiveness in terminating seizures. Lorazepam is typically administered intravenously.</p><p>&nbsp;</p><p><strong>4. IV Fosphenytoin:&nbsp;</strong>If seizures continue after the administration of a benzodiazepine, IV fosphenytoin (or phenytoin) is used as a second-line agent. It helps to stabilize neuronal membranes and prevent further seizure activity.</p><p>&nbsp;</p><p><strong>3. Midazolam, Propofol, Thiopentone:&nbsp;</strong>These agents are used if seizures persist despite initial treatments. Midazolam can be administered intramuscularly or intravenously, while propofol and thiopentone are typically reserved for refractory status epilepticus and may require the child to be in an intensive care setting due to the need for mechanical ventilation and close monitoring.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The management of status epilepticus in children should follow a systematic approach: securing the airway and ensuring breathing, administering a benzodiazepine, followed by fosphenytoin if seizures persist, and considering more potent agents like midazolam, propofol, or thiopentone if the status epilepticus is refractory to initial treatments.</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture122.jpg\" alt=\"\" width=\"600\" height=\"739\"></p>",
      "correct_choice_id": 41641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10127,
      "choices": [
        {
          "id": 40474,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D dependent rickets</span></p>"
        },
        {
          "id": 40475,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 40476,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic renal failure</span></p>"
        },
        {
          "id": 40477,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old girl born out of non-consanguineous marriage presented with rachitic changes in limbs since 1½ years of age for which she has received multiple courses of vitamin D. Investigations showed the following. What is the most likely diagnosis? (NEET PG 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0d2aJYF.png\" width=\"863\" height=\"559\"></p>",
      "unique_key": "Q9124598",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618558,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypophosphatemic rickets</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario of a child with resistant rickets and the following laboratory findings—normal serum calcium, normal parathyroid hormone, decreased serum phosphate, increased alkaline phosphatase, decreased 1,25-dihydroxyvitamin D, increased urinary phosphate, decreased urinary calcium, and normal ABG and serum creatinine—is highly suggestive of hypophosphatemic rickets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypophosphatemic Rickets:&nbsp;</strong>This condition is characterized by low serum phosphate due to renal phosphate wasting, leading to rickets despite normal or elevated levels of vitamin D. It is often caused by mutations affecting phosphate-regulating genes like PHEX.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Laboratory Findings:&nbsp;</strong>The hallmark of this condition includes low serum phosphate, high alkaline phosphatase, normal serum calcium and parathyroid hormone levels, and increased urinary phosphate excretion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin D dependent rickets:&nbsp;</strong>This would typically show low calcium and elevated parathyroid hormone levels due to impaired vitamin D metabolism or action. Serum phosphate may also be low, but the distinguishing factor is the response to vitamin D therapy, which is absent in hypophosphatemic rickets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypoparathyroidism:&nbsp;</strong>This condition usually presents with low calcium and high phosphate levels due to insufficient parathyroid hormone. The given case has normal calcium and low phosphate, making hypoparathyroidism unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chronic renal failure:&nbsp;</strong>This would typically show elevated serum creatinine along with abnormalities in calcium and phosphate metabolism. The normal creatinine level in this patient rules out chronic renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypophosphatemic rickets is characterized by low serum phosphate, normal calcium and parathyroid hormone levels, and increased urinary phosphate due to renal phosphate wasting, commonly due to PHEX gene mutations.</span></p>",
      "correct_choice_id": 40477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10312,
      "choices": [
        {
          "id": 41214,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroids</span></p>"
        },
        {
          "id": 41215,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivermectin</span></p>"
        },
        {
          "id": 41216,
          "text": "<p><span style=\"font-size:12.0pt;\">Remdesivir</span></p>"
        },
        {
          "id": 41217,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is given as a part of the therapy for a child with severe COVID? </span><span style=\"font-size:10.5pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2021)</span></p>",
      "unique_key": "Q4067670",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618559,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Corticosteroids.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of severe COVID-19 in children, corticosteroids are the primary treatment among the given options. Corticosteroids are recommended for children with severe cases, which include conditions like acute respiratory distress syndrome (ARDS), severe pneumonia, septic shock, and multi-organ dysfunction syndrome (MODS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe COVID-19 is characterized by symptoms such as SpO2 less than 90% on room air, severe chest retractions, grunting, lethargy, and signs of pneumonia with cyanosis. In these cases, corticosteroids like Dexamethasone or Methylprednisolone are used to reduce inflammation and manage the severe immune response associated with the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Guidelines for Steroid Use in Severe COVID-19:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Indications:</strong> Corticosteroids are indicated in rapidly progressive moderate cases and all severe cases. They are generally avoided in the first 3-5 days of illness due to the risk of increased viral shedding during this period.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dosage:</strong> Dexamethasone is given at a dose of 0.15 mg/kg with a maximum dose of 6 mg once a day, or Methylprednisolone at 0.75 mg/kg with a maximum dose of 30 mg once a day.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Duration:</strong> The treatment typically continues for 5-6 days and then is tapered off.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ivermectin</strong>: Ivermectin is not recommended for the treatment of severe COVID-19 in children. Ivermectin has been used for deworming, not for treating COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Remdesivir</strong>: Remdesivir is an antiviral medication used in some hospitalized patients with mild to moderate COVID-19 but is not the primary treatment for severe cases in children. It inhibits viral replication by terminating RNA transcription prematurely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corticosteroids are recommended for the treatment of severe COVID-19 in children to manage inflammation and the severe immune response associated with the virus.</span></p>",
      "correct_choice_id": 41214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10288,
      "choices": [
        {
          "id": 41118,
          "text": "<p><span style=\"font-size:12pt;\">PSGN</span></p>"
        },
        {
          "id": 41119,
          "text": "<p><span style=\"font-size:12pt;\">Nephrolithiasis</span></p>"
        },
        {
          "id": 41120,
          "text": "<p><span style=\"font-size:12pt;\">Posterior Urethral Valve</span></p>"
        },
        {
          "id": 41121,
          "text": "<p><span style=\"font-size:12pt;\">Minimal change disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with brown-colored urine and oliguria for the last 3 days. He has mild facial and pedal edema. His blood pressure is 126/90. He has 2+ proteinuria with &gt;100 red cells/HPF and a few granular casts. His creatinine is 0.9, urea is 56. What is the likely diagnosis? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q4637461",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) PSGN</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical picture points to post-streptococcal glomerulonephritis. (PSGN).</span></li><li><span style=\"font-size:12pt;\">PSGN is characterised by sudden onset of gross hematuria, edema, hypertension, and renal insufficiency.</span></li><li><span style=\"font-size:12pt;\">Most children recover entirely from hematuria and proteinuria within 3-6 weeks of the beginning of nephritis after a throat infection with nephritogenic strains of group A -hemolytic streptococci. However, between 3 and 10% of children may have persistent microscopic hematuria, non-nephrotic proteinuria, or hypertension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Light microscopy</strong> reveals larger, pale glomeruli with diffuse mesangial proliferation and an increase in the mesangial matrix in PSGN. In the early stages, polymorph neutrophils (PMN) infiltrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">I<strong>mmunofluorescence</strong>: \"Lumpy-bumpy\" IgG and complement deposits on the glomerular basement membrane (GBM) and</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Electron microscopy</strong>- humps are seen on epithelial side of glomerular basement membrane</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture2_rNIeuAB.jpg\" alt=\"\" width=\"400\" height=\"277\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nephrolithiasis:</strong> Nephrolithiasis will have features of kidney stones in ultrasound. Symptoms: dysuria, hypogastric pain, hematuria &amp; repeated urinary infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Posterior Urethral Valve</strong>: this is one of the cause of distal urinary tract obstruction in boys. Clinical features, abnormal urinary stream, dribbling, palpable bladder &amp; recurrent UTI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Minimal change disease</strong>: Blood pressure of the patient will be normal. </span><span style=\"color:#666060;font-size:12pt;\">Electron microscopy shows nonspecific obliteration of epithelial foot processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sudden onset of gross hematuria, edema, hypertension, and renal insufficiency are indicative of PSGN.</span></p>",
      "correct_choice_id": 41118,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10405,
      "choices": [
        {
          "id": 41586,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 41587,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 41588,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 41589,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following marked structure is damaged in respiratory distress syndrome?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/113.jpg\" alt=\"\" width=\"300\" height=\"275\"></span></p>",
      "unique_key": "Q6824920",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618561,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked as <strong>2</strong> represents <strong>Type II pneumocytes</strong>, which are crucial in the pathophysiology of respiratory distress syndrome (RDS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Type I pneumocytes (Marked as 1):</strong> These cells are large and flattened, making up the majority of the alveolar surface area. They form the thin barrier necessary for efficient gas exchange.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type II pneumocytes (Marked as 2):</strong> These cells are rounded and responsible for producing surfactant, a substance composed of phospholipids and proteins that reduces surface tension within the alveoli. Surfactant is essential for preventing alveolar collapse (atelectasis) during exhalation. In respiratory distress syndrome, especially in premature infants, the deficiency or dysfunction of these Type II cells leads to insufficient surfactant production, causing the alveoli to collapse and resulting in severe breathing difficulties.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Endothelial cells of capillaries (Marked as 3):</strong> These cells line the blood vessels within the lungs and are involved in the exchange of gases between the blood and alveoli. They are not primarily involved in the pathogenesis of RDS.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Red Blood Cells (Marked as 4):</strong> These are the cells responsible for carrying oxygen from the lungs to the rest of the body and returning carbon dioxide to the lungs for exhalation. While essential for overall respiratory function, they are not the site of damage in RDS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Relevance:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Respiratory Distress Syndrome (RDS):</strong> Commonly seen in premature infants, RDS is primarily caused by a deficiency of surfactant due to immature Type II pneumocytes. The lack of surfactant leads to increased surface tension, alveolar collapse, and severe respiratory distress. This condition is a leading cause of morbidity and mortality in preterm infants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Type II pneumocytes are crucial for surfactant production and alveolar stability, and their dysfunction or immaturity is the primary cause of respiratory distress syndrome (RDS) in neonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/114.jpg\" alt=\"\" width=\"500\" height=\"242\"></span></p>",
      "correct_choice_id": 41587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10378,
      "choices": [
        {
          "id": 41478,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral Myositis</span></p>"
        },
        {
          "id": 41479,
          "text": "<p><span style=\"font-size:12.0pt;\">Duchenne</span></p>"
        },
        {
          "id": 41480,
          "text": "<p><span style=\"font-size:12.0pt;\">GBS</span></p>"
        },
        {
          "id": 41481,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old child presents with leg pain. She had fever and cough 3 days prior. Currently, there is pain on palpation of the calf muscles. Reflexes and other clinical examinations are normal. Lab test reveals CK levels of 2000 IU. What is the likely diagnosis? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1409670",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Viral myositis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation described is most consistent with <strong>viral myositis</strong>. Viral myositis is an inflammation of the muscles caused by viral infection, often following an upper respiratory tract illness. The condition is characterized by the following features:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Recent viral illness:</strong> The history of fever and cough 3 days prior suggests a preceding viral infection, which is a common trigger for viral myositis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Leg pain and muscle tenderness:</strong> Viral myositis often presents with significant muscle soreness, especially in the calf muscles, leading to pain on palpation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated creatine kinase (CK) levels:</strong> The CK level of 2000 IU indicates muscle injury or inflammation, which is consistent with viral myositis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Normal reflexes and neurological examination:</strong> This helps differentiate viral myositis from other conditions like Guillain-Barré Syndrome (GBS) or Duchenne muscular dystrophy, which would typically present with abnormal reflexes or progressive muscle weakness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Influenza</strong> is a common viral cause of myositis, particularly in children. The muscle pain typically begins 1-7 days after the onset of the viral illness and may lead to difficulty walking, often with a characteristic toe-walking gait due to involvement of the gastrocnemius-soleus muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Duchenne:</strong> Duchenne muscular dystrophy is a genetic disorder characterized by progressive muscle degeneration and weakness, typically presenting with proximal muscle weakness, calf pseudohypertrophy, and elevated CK levels. However, it does not present acutely following a viral illness and usually starts earlier in life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. GBS (Guillain-Barré Syndrome):</strong> GBS is an autoimmune condition that causes ascending paralysis, starting with weakness in the legs. Reflexes are usually diminished or absent in GBS, unlike the normal reflexes observed in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dermatomyositis:</strong> Dermatomyositis is an inflammatory muscle disease characterized by muscle weakness and a distinctive skin rash. It usually presents with chronic, progressive weakness rather than acute pain following a viral illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Viral myositis is characterized by muscle pain, especially in the calves, following a viral infection, with elevated CK levels and normal reflexes, distinguishing it from other neuromuscular conditions.</span></p>",
      "correct_choice_id": 41478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10387,
      "choices": [
        {
          "id": 41514,
          "text": "<p><span style=\"font-size:12.0pt;\">Stercobilin</span></p>"
        },
        {
          "id": 41515,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumirubin</span></p>"
        },
        {
          "id": 41516,
          "text": "<p><span style=\"font-size:12.0pt;\">Biliverdin</span></p>"
        },
        {
          "id": 41517,
          "text": "<p><span style=\"font-size:12.0pt;\">Urobilin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Phototherapy converts bilirubin to?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2020)</span></p>",
      "unique_key": "Q7840589",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618563,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lumirubin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phototherapy is a standard treatment for neonatal jaundice and indirect hyperbilirubinemia. The primary purpose of phototherapy is to reduce elevated bilirubin levels in the blood by converting the toxic unconjugated bilirubin into a form that can be more easily excreted by the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanisms involved in phototherapy:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Irreversible Structural Isomerization:&nbsp;</strong>This is the most important mechanism of phototherapy. It converts bilirubin into <strong>lumirubin</strong>, a more water-soluble isomer that can be excreted by the kidneys in an unconjugated form. Lumirubin is more easily excreted in the urine, reducing serum bilirubin levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reversible Photo-isomerization Reaction:&nbsp;</strong>This process converts toxic unconjugated bilirubin into a non-toxic configurational isomer, which can be excreted in the bile without conjugation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Photo-oxidation:&nbsp;</strong>This is a minor mechanism where bilirubin undergoes oxidation to form colorless products that are also excreted.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Contraindications:&nbsp;</strong>Phototherapy is contraindicated in conditions like porphyria, where exposure to light can cause severe photosensitivity and blistering.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stercobilin:&nbsp;</strong>This is a bile pigment formed from the breakdown of bilirubin in the intestines, giving stool its characteristic brown color. It is not directly involved in the process of phototherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Biliverdin:&nbsp;</strong>Biliverdin is a precursor to bilirubin in the heme breakdown pathway. Phototherapy does not convert bilirubin back to biliverdin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urobilin:&nbsp;</strong>Urobilin is a product of bilirubin metabolism that is excreted in the urine, giving urine its yellow color. It is not the primary product of phototherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phototherapy converts bilirubin into lumirubin, a water-soluble isomer that can be excreted by the kidneys, making it an effective treatment for neonatal jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/90_Do8nZuQ.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p>",
      "correct_choice_id": 41515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61372,
      "choices": [
        {
          "id": 244765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Avian influenza</span></span></span></p>"
        },
        {
          "id": 244766,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parainfluenza</span></span></span></p>"
        },
        {
          "id": 244767,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory syncytial virus (RSV)</span></span></span></p>"
        },
        {
          "id": 244768,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coxsackie virus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Palivizumab is a humanized monoclonal antibody. For which condition is it approved?</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q8969641",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618564,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: C. Respiratory syncytial virus (RSV)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Palivizumab is specifically approved for the prevention and treatment of respiratory syncytial virus (RSV) infections. It is particularly recommended for infants at high risk, such as those born prematurely or with conditions like congenital heart disease or chronic lung disease. Palivizumab works by providing passive immunity against RSV, reducing the severity and incidence of RSV-related illnesses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Avian influenza</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Palivizumab is not used for treating or preventing avian influenza.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Parainfluenza</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Palivizumab is not indicated for parainfluenza infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Coxsackie virus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Palivizumab is not used for Coxsackie virus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Palivizumab is approved for preventing and treating respiratory syncytial virus (RSV) infections in high-risk infants.</span></span></span></p>",
      "correct_choice_id": 244767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10106,
      "choices": [
        {
          "id": 40390,
          "text": "<p><span style=\"font-size:12.0pt;\">Kwashiorkor</span></p>"
        },
        {
          "id": 40391,
          "text": "<p><span style=\"font-size:12.0pt;\">Marasmus</span></p>"
        },
        {
          "id": 40392,
          "text": "<p><span style=\"font-size:12.0pt;\">Indian childhood cirrhosis</span></p>"
        },
        {
          "id": 40393,
          "text": "<p><span style=\"font-size:12.0pt;\">Kawasaki disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A laborer's second child is brought to the OPD with a swollen belly and dull face. He has been fed rice water (rice milk) in his diet mostly. On investigations, the child is found to have low serum protein and low albumin. What is the probable diagnosis? (NEET PG 2020)</span></p>",
      "unique_key": "Q3599390",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618565,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kwashiorkor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of a swollen belly and dull face in a child fed mostly rice water, along with findings of low serum protein and low albumin, is suggestive of Kwashiorkor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Kwashiorkor&nbsp;</strong>is a form of severe acute malnutrition characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Edema:&nbsp;</strong>Resulting from hypoalbuminemia, which leads to fluid retention and swelling, especially in the abdomen.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Apathy and irritability:&nbsp;</strong>The child often appears listless and irritable.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Poor diet history:&nbsp;</strong>Often associated with diets low in protein, such as those predominantly consisting of carbohydrates like rice water.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other symptoms:&nbsp;</strong>Growth retardation, muscle wasting, and skin and hair changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Marasmus:&nbsp;</strong>Marasmus is another form of severe acute malnutrition but is characterized by severe wasting and absence of edema. Children with marasmus appear extremely thin with prominent ribs and have a \"skin and bones\" appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Indian childhood cirrhosis:&nbsp;</strong>This is a chronic liver disease in children characterized by liver fibrosis and cirrhosis, but it does not typically present with the acute signs of protein malnutrition like Kwashiorkor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Kawasaki disease:&nbsp;</strong>This is an acute febrile illness of unknown etiology that primarily affects children under 5 years of age and involves inflammation of blood vessels (vasculitis). It does not present with symptoms of malnutrition such as a swollen belly due to low protein intake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kwashiorkor is characterized by edema, apathy, and growth retardation due to a diet deficient in protein, often with a swollen belly and low serum protein levels.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture148.jpg\" alt=\"\" width=\"500\" height=\"299\"></p>",
      "correct_choice_id": 40390,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11647,
      "choices": [
        {
          "id": 46554,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">To be done in lateral recumbent position</span></p>"
        },
        {
          "id": 46555,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Breath holding is not necessary</span></p>"
        },
        {
          "id": 46556,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">The bevel should face upwards while inserting the needle.</span></p>"
        },
        {
          "id": 46557,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Coagulopathy is not a contraindication.</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Regarding the procedure done with the needle shown below, which of the following is false?</span><span style=\"font-size:12.0pt;\"> (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm108.jpg\" alt=\"\" width=\"400\" height=\"302\"></span></p>",
      "unique_key": "Q5641428",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618566,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Coagulopathy is not a contraindication.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts a spinal needle used primarily for lumbar puncture (LP), a procedure where cerebrospinal fluid (CSF) is collected from the lumbar cistern. The procedure can be conducted in either the lateral recumbent position or sitting position, depending on the patient's comfort and the physician's preference. The bevel orientation during insertion affects the dural fibers; positioning it parallel (typically upwards) minimizes dural fiber tearing and the subsequent likelihood of post-lumbar puncture headaches. Importantly, coagulopathy is a significant contraindication for lumbar puncture due to the increased risk of spinal hematoma and severe complications associated with bleeding around the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To be done in lateral recumbent position:</strong> This is true and is one of the standard positions for performing an LP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Breath holding is not necessary:</strong> During LP, patients are advised to breathe normally to avoid increases in intra-abdominal and intrathoracic pressure, which could affect CSF dynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The bevel should face upwards while inserting the needle:</strong> This is a recommended practice to reduce the risk of post-procedure complications, such as a post-dural puncture headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coagulopathy is a contraindication for lumbar puncture due to the risk of bleeding and potential for serious complications, contrary to the incorrect statement provided. Always assess the patient’s coagulation status prior to performing an LP.</span></p>",
      "correct_choice_id": 46557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20340,
      "choices": [
        {
          "id": 81321,
          "text": "<p><span style=\"font-size:12.0pt;\">Crigler-Najjar syndrome</span></p>"
        },
        {
          "id": 81322,
          "text": "<p><span style=\"font-size:12.0pt;\">Rotor syndrome</span></p>"
        },
        {
          "id": 81323,
          "text": "<p><span style=\"font-size:12.0pt;\">Dubin-Johnson syndrome</span></p>"
        },
        {
          "id": 81324,
          "text": "<p><span style=\"font-size:12.0pt;\">Biliary atresia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-month-old baby is brought to OPD with jaundice and clay-colored stools. Lab work up reveals that the baby has conjugated hyperbilirubinemia. A liver biopsy was done and shows periductal proliferation. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q5692499",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618567,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Biliary atresia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An infant with jaundice, clay-coloured stools, and periductal proliferation on liver biopsy is highly suggestive of biliary atresia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An infant with Biliary atresia presents with progressive jaundice, persistent yellow stools, and palpable liver with abnormal consistency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laboratory investigations show conjugated hyperbilirubinemia. Ultrasonography reveals a triangular-cord sign (cone-shaped fibrotic mass cranial to the bifurcation of the portal vein).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">HIDA test is more relevant for its negative predictive value (100%). Liver biopsy is diagnostic for biliary atresia. In biliary atresia, portal tract expansion, ductular proliferation and fibrosis is seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laparotomy and perioperative cholangiography may be required in an infant with equivocal biopsy, findings and no excretion on HIDA scan, to evaluate for biliary atresia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Biliary atresia is managed by Kasai procedure (hepato-portoenterostomy).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-154249.png\" alt=\"\" width=\"1000\" height=\"467\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Crigler-Najjar syndrome:&nbsp;</strong>This is characterized by absent or deficient UGT enzyme leading to increased unconjugated bilirubin. It does not present with conjugated hyperbilirubinemia or clay-colored stools.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rotor syndrome:&nbsp;</strong>A mild form of Dubin-Johnson syndrome that causes conjugated hyperbilirubinemia, but without the dark liver appearance seen in Dubin-Johnson syndrome. It does not present with periductal proliferation on liver biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Dubin-Johnson syndrome:&nbsp;</strong>Characterized by increased conjugated bilirubin and a dark liver appearance. It is an autosomal recessive disorder but does not present with the same liver biopsy findings as biliary atresia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An infant presenting with jaundice, clay-colored stools, and periductal proliferation on liver biopsy is highly suggestive of biliary atresia.</span></p>",
      "correct_choice_id": 81324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54512,
      "choices": [
        {
          "id": 217517,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyper IgE syndrome</span></p>"
        },
        {
          "id": 217518,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease</span></p>"
        },
        {
          "id": 217519,
          "text": "<p><span style=\"font-size:12.0pt;\">Bruton disease</span></p>"
        },
        {
          "id": 217520,
          "text": "<p><span style=\"font-size:12.0pt;\">Wiskott Aldrich syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following immunodeficiency disorders has a high chance of catalase positive organisms causing infections?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4196446",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618568,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chronic granulomatous disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease (CGD) is an immunodeficiency disorder characterized by a defect in the NADPH oxidase complex. This defect impairs the ability of phagocytes to produce reactive oxygen species, which are crucial for killing certain bacteria and fungi. As a result, individuals with CGD are particularly susceptible to infections by catalase-positive organisms, which can neutralize hydrogen peroxide and thus evade destruction by the impaired phagocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyper IgE syndrome:</strong> Also known as Job syndrome, this disorder is characterized by high levels of IgE, recurrent skin abscesses, pneumonia, and characteristic facial features. It is not specifically associated with increased infections by catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bruton disease:</strong> Also known as X-linked agammaglobulinemia, this condition affects B cell development, leading to low levels of immunoglobulins and increased susceptibility to bacterial infections, but not specifically to catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wiskott Aldrich syndrome:</strong> This is an X-linked recessive disorder characterized by eczema, thrombocytopenia, and immunodeficiency. While patients have an increased risk of infections, the susceptibility to catalase-positive organisms is not as pronounced as in CGD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease is associated with a high risk of infections by catalase-positive organisms due to a defect in the NADPH oxidase complex, which impairs the killing of these organisms by phagocytes.</span></p>",
      "correct_choice_id": 217518,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11037,
      "choices": [
        {
          "id": 44114,
          "text": "<p><span style=\"font-size:18px;\">Only vial 1 can be used</span></p>"
        },
        {
          "id": 44115,
          "text": "<p><span style=\"font-size:18px;\">Vials 1 and 2 can be used</span></p>"
        },
        {
          "id": 44116,
          "text": "<p><span style=\"font-size:18px;\">Vials 1, 2, and 3 can be used</span></p>"
        },
        {
          "id": 44117,
          "text": "<p><span style=\"font-size:18px;\">All vials can be used</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Dr. Sunita, a medical officer in a rural health clinic, is tasked with ensuring the potency and safety of vaccines. She comes across several vaccine vials, each with a Vaccine Vial Monitor (VVM) attached. The VVMs change color to indicate the cumulative exposure of the vaccine to heat, thus helping in determining the viability of the vaccine. She notices varying degrees of color changes across these VVMs. Given this scenario, which of the following choices correctly identifies which vaccine vials, based on the observed VVM color changes, should be considered safe for use? (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-113411.png\" alt=\"\" width=\"200\" height=\"1073\"></span></p>",
      "unique_key": "Q5219256",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618569,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(b) Vials 1 and 2 can be used</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Based on the image provided, it's evident that only vials 1 and 2 are suitable for use because the inner squares of these vials color lighter than the outer circles.</span></li><li><span style=\"font-size:18px;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"font-size:18px;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"font-size:18px;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"font-size:18px;\">Expiry date can’t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"font-size:18px;\">If the square and the circle are the same in colour, then the vaccine should be discarded.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture2.jpg\" alt=\"\" width=\"700\" height=\"372\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture1_YnCLGDy.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p>",
      "correct_choice_id": 44115,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10181,
      "choices": [
        {
          "id": 40690,
          "text": "<p><span style=\"font-size:12.0pt;\">Azathioprine</span></p>"
        },
        {
          "id": 40691,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 40692,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporine</span></p>"
        },
        {
          "id": 40693,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male child presented with arthralgia and abdominal pain. On examination, there was palpable purpura over the lower limbs. There is a past history of upper respiratory tract infection prior to the onset of presenting symptoms. Which of the following is the treatment for this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q8466847",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618570,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Glucocorticoids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario is suggestive of Henoch Schonlein's purpura (HSP). Glucocorticoids are used to treat HSP.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture144.jpg\" alt=\"\" width=\"1000\" height=\"715\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Azathioprine:&nbsp;</strong>Azathioprine is an immunosuppressant that may be used in severe cases of HSP with nephritis, but it is not the first-line treatment for the initial presentation of HSP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methotrexate:&nbsp;</strong>Methotrexate is used in various autoimmune and inflammatory conditions, but it is not typically used for the treatment of HSP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cyclosporine:&nbsp;</strong>Cyclosporine is an immunosuppressive agent used in certain conditions, including severe nephritis, but it is not the first-line treatment for HSP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary treatment for Henoch-Schönlein purpura (HSP), particularly with significant gastrointestinal involvement or severe symptoms, is glucocorticoids such as prednisolone.</span></p>",
      "correct_choice_id": 40693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61376,
      "choices": [
        {
          "id": 244781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Escherichia coli</span></span></span></p>"
        },
        {
          "id": 244782,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Streptococcus agalactiae</span></span></span></p>"
        },
        {
          "id": 244783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Staphylococcus aureus</span></span></span></p>"
        },
        {
          "id": 244784,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Listeria monocytogenes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 12-day-old neonate presents to the emergency department with increased irritability, poor feeding, and two episodes of seizures. Physical examination reveals a bulging fontanelle and lethargy. A lumbar puncture shows elevated white blood cells, high protein, and low glucose, suggestive of bacterial meningitis. What is the most likely causative organism?</span></span></span></p>",
      "unique_key": "Q7431579",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Streptococcus agalactiae</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neonatal meningitis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is suspected in this clinical scenario. The most likely causative organism is <strong>Streptococcus agalactiae (Group B streptococcus)</strong>, which is the leading cause of neonatal meningitis and sepsis. It commonly affects both early-onset (within the first 72 hours of life) and late-onset neonatal infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Early-onset meningitis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> occurs within the first 72 hours of life and is mainly caused by Group B streptococci. In contrast, <strong>late-onset meningitis</strong> typically affects premature infants and is often caused by coagulase-negative staphylococci, such as Staphylococcus aureus, Escherichia coli, and Klebsiella.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Group B streptococci are the most common cause of neonatal sepsis and meningitis in full-term infants. <strong>Escherichia coli</strong> is the most common cause of early-onset sepsis and meningitis in very low birth weight infants (less than 1500 g), but it is less common than Group B streptococcus in full-term infants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neonates have immature cellular and humoral immunity,</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> making them more susceptible to infections like meningitis and sepsis. Any infant aged 28 days or younger with fever or signs of sepsis should be promptly evaluated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The evaluation for sepsis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> includes a complete blood count (CBC), differential count, blood culture, urine culture, chest radiograph, and lumbar puncture. These tests help identify the causative organism and determine appropriate treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Escherichia coli:</strong> Although a common cause of neonatal meningitis, especially in preterm and very low birth weight infants, it is less frequent in full-term infants compared to Group B streptococcus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Staphylococcus aureus:</strong> Typically associated with late-onset infections, particularly in hospitalized infants or those with central lines, but not as common in the early neonatal period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D) Listeria monocytogenes:</strong> A less common cause of neonatal meningitis, often linked to maternal risk factors, such as consumption of contaminated food, and not the most likely in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Streptococcus agalactiae (Group B streptococcus) is the primary cause of neonatal meningitis and sepsis, particularly in full-term infants. Due to the neonate&rsquo;s immature immune system, early recognition and management of these infections are crucial to prevent severe complications.</span></span></span></p>",
      "correct_choice_id": 244782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33321,
      "choices": [
        {
          "id": 133130,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 133131,
          "text": "<p><span style=\"font-size:12.0pt;\">Hearing loss</span></p>"
        },
        {
          "id": 133132,
          "text": "<p><span style=\"font-size:12.0pt;\">Short stature</span></p>"
        },
        {
          "id": 133133,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudal regression syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not seen in Downs syndrome?&nbsp; (</span>INICET Nov 2023)</p>",
      "unique_key": "Q8633052",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618572,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Caudal regression syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Caudal regression syndrome is not typically associated with Down syndrome. Caudal regression syndrome is a congenital disorder characterized by abnormal development of the lower spine (caudal region). It is a separate condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Hypothyroidism: </strong>Hypothyroidism is a known association with Down syndrome.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Hearing loss: </strong>Hearing loss is commonly observed in individuals with Down syndrome. Ear infections and structural abnormalities may contribute to this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Short stature: </strong>Short stature is a characteristic feature of Down syndrome. Individuals with Down syndrome often have a shorter stature compared to the general population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the common clinical features and associated conditions of Down syndrome. Understand that hypothyroidism, hearing loss, and short stature are commonly observed in individuals with Down syndrome. Be aware of the distinct features of other congenital conditions, such as caudal regression syndrome, that are not typically associated with Down syndrome.</span></p>",
      "correct_choice_id": 133133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5198,
      "choices": [
        {
          "id": 20765,
          "text": "<p><span style=\"font-size:12.0pt;\">Reinke's edema</span></p>"
        },
        {
          "id": 20766,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignancy</span></p>"
        },
        {
          "id": 20767,
          "text": "<p><span style=\"font-size:12.0pt;\">Tracheomalacia</span></p>"
        },
        {
          "id": 20768,
          "text": "<p><span style=\"font-size:12.0pt;\">Laryngeal papilloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the lesion of vocal cord in the image given below: (NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_224.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p>",
      "unique_key": "Q8308919",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618573,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Laryngeal papilloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts laryngeal papilloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Laryngeal papillomatosis (juvenile papillomatosis)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Juvenile papillomatosis is the most common benign neoplasm of the larynx in children.</span></li><li><span style=\"font-size:12.0pt;\">It is viral in origin and is caused by human papilloma virus type 6 and 11.</span></li><li><span style=\"font-size:12.0pt;\">It is presumed that affected children got the disease at birth from their mothers who had vaginal human papillomavirus disease.</span></li><li><span style=\"font-size:12.0pt;\">Papilloma’s mostly affect supraglottic and glottic regions of the larynx but can also involve subglottis, trachea and bronchi. DNA virus particles have been found in the cells of the basement membrane of respiratory mucosa and may account for widespread involvement and recurrence.</span></li><li><span style=\"font-size:12.0pt;\">Patients, often a child, between the age of 3 and 5 years present with hoarseness or aphonia with respiratory difficulty or even stridor.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis is made by flexible fiberoptic laryngoscopy and later confirmed by direct laryngoscopy and biopsy.</span></li><li><span style=\"font-size:12.0pt;\">Papillomas are known for recurrence but rarely undergo malignant change.</span></li><li><span style=\"font-size:12.0pt;\">Treatment consists of microlaryngoscopy and CO2 laser excision avoiding injury to vocal ligament. Other modalities of tumor removal are with cold steel instruments or&nbsp; debrider or coblation or radiofrequency. Aim of therapy is to maintain a good airway, preserve voice and avoid recurrence.</span></li><li><span style=\"font-size:12.0pt;\">Adjuvant medical therapies include Interferon alpha-2a and 13-cis-retinoic acid has been used.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Reinke's edema</strong> - Characterized by swelling of the vocal cords due to fluid accumulation, not similar to the warty growths of papillomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Malignancy</strong> - Would typically appear more irregular and could involve more invasive growth patterns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tracheomalacia</strong> - A condition related to the softening of the tracheal walls, not relevant to laryngeal lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laryngeal papilloma is a significant pediatric condition caused by HPV, manifesting as benign, wart-like growths within the larynx. While these tumors are prone to recurrence, they rarely undergo malignant transformation, making careful ongoing monitoring and management essential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 345</strong></span></p>",
      "correct_choice_id": 20768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10420,
      "choices": [
        {
          "id": 41646,
          "text": "<p><span style=\"font-size:12.0pt;\">3-1-2-5-4</span></p>"
        },
        {
          "id": 41647,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2-3-4-5</span></p>"
        },
        {
          "id": 41648,
          "text": "<p><span style=\"font-size:12.0pt;\">3-1-2-4-5</span></p>"
        },
        {
          "id": 41649,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2-4-3-5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An unconscious child is brought to the casualty. What is the correct sequence of the management? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Assess breathing</span></li><li><span style=\"font-size:12.0pt;\">Assess pulse</span></li><li><span style=\"font-size:12.0pt;\">Assess response</span></li><li><span style=\"font-size:12.0pt;\">Start compressions</span></li><li><span style=\"font-size:12.0pt;\">Bag and mask ventilation</span></li></ol>",
      "unique_key": "Q4988829",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3-1-2-4-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When managing an unconscious child, especially in a potential cardiac or respiratory arrest scenario, it is crucial to follow the steps of <strong>Basic Life Support (BLS)</strong> in the correct sequence to ensure the best chance of recovery.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-06-17%20at%2016.35.35_1a8b87e8.jpg\" width=\"1280\" height=\"718\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sequence Justification:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The correct sequence is <strong>3-1-2-4-5</strong>, which means:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>3:&nbsp;</strong>First, assess response (to determine unresponsiveness).</span></li><li><span style=\"font-size:12.0pt;\"><strong>1:&nbsp;</strong>Then assess breathing (to check for normal breathing).</span></li><li><span style=\"font-size:12.0pt;\"><strong>2:&nbsp;</strong>Followed by assessing the pulse (to check for circulation).</span></li><li><span style=\"font-size:12.0pt;\"><strong>4:&nbsp;</strong>Start compressions if necessary (if no pulse or poor perfusion).</span></li><li><span style=\"font-size:12.0pt;\"><strong>5:&nbsp;</strong>Provide bag and mask ventilation to support breathing.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In BLS, the correct sequence of actions is crucial for effective management. Start by assessing response, followed by breathing and pulse, then initiate compressions and ventilation as needed.</span></p>",
      "correct_choice_id": 41648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10383,
      "choices": [
        {
          "id": 41498,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Steroid resistant glomerulonephritis</span></p>"
        },
        {
          "id": 41499,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Minimal change disease</span></p>"
        },
        {
          "id": 41500,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Rapidly progressive glomerulonephritis</span></p>"
        },
        {
          "id": 41501,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Chronic glomerulonephritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Effacement of podocyte foot processes is seen in which of the following diseases? (NEET PG 2020)</span></p>",
      "unique_key": "Q5094321",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618575,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Minimal change disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Effacement of the podocyte foot processes is characteristically seen in minimal change disease (MCD), which is also called <strong>lipoid nephrosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On light microscopy, characteristic feature is no apparent abnormality in the glomeruli except for slight increase in the mesangial matrix at the most.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/minimal-change-disease.jpg\" alt=\"\" width=\"300\" height=\"222\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">By electron microscopy, the most characteristic feature of the disease is identified which is diffuse flattening of foot processes of the visceral epithelial cells (podocytes) and, hence, the name foot process disease or podocytopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast to other types of GN, no deposits are visible, and the GBM is normal. No complement or immunoglobulin deposits are detected using immunofluorescence microscopy (nil deposit disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's also seen in other diseases like membranous nephropathy and focal segmental glomerulosclerosis. These diseases are also known as podocytopathies because they affect podocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Steroid resistant glomerulonephritis:&nbsp;</strong>This term is more of a clinical description rather than a specific pathological diagnosis. Steroid-resistant cases can include various glomerulonephritis types such as focal segmental glomerulosclerosis (FSGS), which also shows podocyte effacement but is not the classic example of it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rapidly progressive glomerulonephritis (RPGN):&nbsp;</strong>RPGN is characterized by crescent formation in the glomeruli and is associated with severe glomerular damage and rapid loss of kidney function. It does not specifically show effacement of podocyte foot processes as its primary feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic glomerulonephritis:&nbsp;</strong>Chronic glomerulonephritis encompasses various forms of long-standing glomerular diseases leading to chronic kidney damage. It is associated with glomerular sclerosis and interstitial fibrosis but not specifically with podocyte foot process effacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Effacement of podocyte foot processes is the characteristic feature of minimal change disease (MCD), which presents with nephrotic syndrome and shows normal glomeruli on light microscopy but diffuse foot process flattening on electron microscopy.</span></p>",
      "correct_choice_id": 41499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61375,
      "choices": [
        {
          "id": 244777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mid-upper arm circumference (MUAC) &lt;11.5 cm</span></span></span></p>"
        },
        {
          "id": 244778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight-for-length below -3 SD of the WHO child growth standards</span></span></span></p>"
        },
        {
          "id": 244779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight-for-age below -3 SD of the WHO child growth standards</span></span></span></p>"
        },
        {
          "id": 244780,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of bipedal edema</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 2-year-old child presents to the pediatric clinic with signs of malnutrition. The healthcare provider assesses the child&rsquo;s nutritional status to determine if the child meets the criteria for severe acute malnutrition (SAM) according to WHO guidelines. Which of the following is not a criterion for diagnosing severe acute malnutrition?</span></span></span></p>",
      "unique_key": "Q9640456",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618576,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: C. Weight-for-age below -3 SD of the WHO child growth standards</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe acute malnutrition (SAM) is defined by the WHO based on specific criteria that assess acute malnutrition, focusing primarily on body measurements that reflect wasting and the presence of edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">WHO Criteria for Severe Acute Malnutrition (SAM):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mid-upper arm circumference (MUAC) &lt;11.5 cm:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This measurement reflects wasting and is commonly used in the field to quickly assess nutritional status in children aged 6 to 59 months.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight-for-length (or height) below -3 SD of the WHO child growth standards:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This criterion specifically assesses the child&rsquo;s weight relative to their height, indicating severe wasting.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of bipedal edema:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Edema is a clinical sign of severe malnutrition, reflecting a more serious condition that is often associated with metabolic disturbances and increased risk of mortality.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight-for-age below -3 SD:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is not a criterion for SAM. While weight-for-age can indicate undernutrition, it does not differentiate between stunting (chronic malnutrition) and wasting (acute malnutrition), making it less specific for diagnosing SAM.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe acute malnutrition (SAM) is diagnosed based on mid-upper arm circumference, weight-for-length or height below -3 SD, and the presence of bipedal edema. Weight-for-age is not used as a specific criterion for SAM because it does not accurately reflect acute malnutrition. Understanding these criteria is critical for identifying and managing malnutrition in pediatric populations.</span></span></span></p>",
      "correct_choice_id": 244779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20267,
      "choices": [
        {
          "id": 81029,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated histoplasmosis</span></p>"
        },
        {
          "id": 81030,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated cryptococcosis</span></p>"
        },
        {
          "id": 81031,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with molluscum contagiosum</span></p>"
        },
        {
          "id": 81032,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV with tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old HIV-positive male came with complaints of persistent cough and weight loss. He has skin lesions as shown in the image. Chest x-ray showed multiple bilateral nodular infiltrates. His sputum CBNAAT for tuberculosis was negative and he has a low CD4 count. What is the probable diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170533.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p>",
      "unique_key": "Q4719489",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618577,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. HIV with disseminated histoplasmosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient presents with persistent cough, weight loss, and skin lesions. The chest x-ray reveals multiple bilateral nodular infiltrates, and the patient has a low CD4 count. These findings are significant for several reasons:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disseminated histoplasmosis</strong> can mimic tuberculosis, especially in HIV-positive patients. It causes disseminated disease with pulmonary involvement (multiple bilateral nodular infiltrates) and skin lesions. The presence of these lesions and a negative sputum CBNAAT for tuberculosis further supports histoplasmosis, as this fungal infection is common in immunocompromised individuals with low CD4 counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. HIV with disseminated cryptococcosis</strong>: While cryptococcosis can cause lung disease, it more commonly presents with central nervous system involvement, such as meningitis or meningoencephalitis. This patient does not exhibit neurological symptoms, making cryptococcosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV with molluscum contagiosum</strong>: Molluscum contagiosum causes umbilicated papules but does not lead to bilateral nodular infiltrates in the lungs. Thus, this diagnosis is unlikely given the chest x-ray findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HIV with tuberculosis</strong>: Tuberculosis is a common infection in HIV-positive patients and can present with similar symptoms and radiographic findings. However, the negative sputum CBNAAT for tuberculosis makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disseminated histoplasmosis in HIV-positive patients can mimic tuberculosis, presenting with pulmonary nodular infiltrates and skin lesions, especially in those with low CD4 counts.</span></p>",
      "correct_choice_id": 81029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55884,
      "choices": [
        {
          "id": 222969,
          "text": "<p><span style=\"font-size:12.0pt;\">T9</span></p>"
        },
        {
          "id": 222970,
          "text": "<p><span style=\"font-size:12.0pt;\">T10</span></p>"
        },
        {
          "id": 222971,
          "text": "<p><span style=\"font-size:12.0pt;\">T11</span></p>"
        },
        {
          "id": 222972,
          "text": "<p><span style=\"font-size:12.0pt;\">T12</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the vertebral level of section in given image? (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171920.jpeg\" alt=\"\" width=\"300\" height=\"221\"></span></p>",
      "unique_key": "Q8268658",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618578,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) T9</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The provided image shows a cross-sectional anatomy where key structures such as the liver, stomach, heart, and lungs are visible. At the T9 vertebral level, the liver and stomach are seen prominently, with the heart also visible, indicating that the section is at the level where these thoracic and upper abdominal structures overlap. The presence of the lungs further supports that this is a thoracic level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171944.jpeg\" alt=\"\" width=\"500\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171956.jpeg\" alt=\"\" width=\"700\" height=\"348\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cross sectional anatomy of ABDOMEN:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171932.jpeg\" alt=\"\" width=\"700\" height=\"721\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. T10:</strong> While the T10 level also shows some of the same structures, the visibility and position of the liver, stomach, heart, and lungs in this image are more indicative of T9.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. T11:</strong> At the T11 level, the kidneys start to become visible, and the heart is usually not as prominent as it is at the T9 level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. T12:</strong> The T12 level typically shows the kidneys more clearly and does not include as much of the heart and upper liver as seen in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The T9 vertebral level in cross-sectional anatomy images often shows the liver, stomach, heart, and lungs, making it a key point for identifying these structures.</span></p>",
      "correct_choice_id": 222969,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3810,
      "choices": [
        {
          "id": 15219,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacteria</span></p>"
        },
        {
          "id": 15220,
          "text": "<p><span style=\"font-size:12.0pt;\">Nocardia</span></p>"
        },
        {
          "id": 15221,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomyces</span></p>"
        },
        {
          "id": 15222,
          "text": "<p><span style=\"font-size:12.0pt;\">Corynebacterium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following slide is given as a spotter in your microbiology practical examination. Identify the following organism? (INICET MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-179.jpg\" alt=\"\" width=\"300\" height=\"228\"></span></p>",
      "unique_key": "Q4009390",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618579,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mycobacteria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The image shows pink non-branching acid-fast bacilli on a blue background. These findings are consistent with the staining characteristics of mycobacteria. The stain used is the Ziehl-Neelsen stain.</span></li><li><span style=\"font-size:12.0pt;\">Nocardia is partially acid-fast and appears as branching filaments.</span></li><li><span style=\"font-size:12.0pt;\">Actinomyces and Corynebacterium are non-acid-fast.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> The image below shows <strong>Nocardia </strong>stained using an acid-fast staining technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-287.jpg\" alt=\"\" width=\"400\" height=\"263\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> The image given below is of a gram-stained specimen of <strong>Actinomyces </strong>israelii.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-288.jpg\" alt=\"\" width=\"400\" height=\"374\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> The images below show the staining characteristics of <strong>Corynebacterium </strong>diphtheriae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-289.jpg\" alt=\"\" width=\"500\" height=\"435\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis, appear as pink bacilli on a blue background when stained with Ziehl-Neelsen stain due to their acid-fast properties.</span></li><li><span style=\"font-size:12.0pt;\">They have a high lipid content in their cell walls, which retains the carbol fuchsin dye even after treatment with acid-alcohol, a hallmark of acid-fast organisms.</span></li></ul>",
      "correct_choice_id": 15219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24718,
      "choices": [
        {
          "id": 98833,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MDR1</span></span></span></p>"
        },
        {
          "id": 98834,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></span></span></p>"
        },
        {
          "id": 98835,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2</span></span></span></p>"
        },
        {
          "id": 98836,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient undergoing renal transplant management was started on cyclosporine as part of the immunosuppressive regimen. Within a few weeks, the patient begins to show elevated liver enzymes and bilirubin levels. The treating physician suspects drug-induced cholestasis and considers the involvement of a specific cellular transporter. Which cellular transporter is most likely responsible for cyclosporine-induced cholestasis in this patient</span></span></span></p>",
      "unique_key": "Q1336214",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618580,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. MRP2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2, also known as Multi-Drug Resistance-associated Protein 2 or ABCC2, is a membrane-bound transporter protein that belongs to the ATP-binding cassette (ABC) family of transporters. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This protein is primarily expressed in the liver, particularly in the canalicular membrane of hepatocytes, as well as in the kidneys, intestines, and other tissues.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 functions as an efflux pump, actively transporting a variety of substances out of cells including bile salts, bilirubin, glucuronides, and various drugs and their metabolites.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 plays a critical role in the efflux of bile salts and bilirubin into the bile canaliculus. Mutations or inhibition of MRP2 (by drugs like cyclosporine) can lead to cholestasis, a condition where bile cannot flow from the liver to the duodenum.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dubin-Johnson Syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a genetic disorder resulting from mutations in the MRP2 gene, leading to conjugated hyperbilirubinemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. MDR 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Multi-Drug Resistance Protein 1 (MDR 1 or P-glycoprotein) is more known for its role in drug resistance, not specifically for cyclosporine-induced cholestasis. While MDR-1 plays a role in drug metabolism and can be inhibited by cyclosporine, it is generally not implicated in the development of drug-induced cholestasis, which is more closely associated with MRP2 inhibition.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The Breast Cancer Susceptibility Gene (BRCA) is not related to drug metabolism or cholestasis. It is mainly involved in DNA repair and cancer susceptibility.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Organic Anion Transporting Polypeptide 1B1 (OATP1B1) is involved in drug uptake into the liver but is not the key player in cyclosporine-induced cholestasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRP2 (Multi-Drug Resistance-associated Protein 2) is the cellular transporter most likely responsible for cyclosporine-induced cholestasis due to its role in the efflux of bile salts and bilirubin into the bile canaliculus.</span></span></span></p>",
      "correct_choice_id": 98835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5802,
      "choices": [
        {
          "id": 23179,
          "text": "<p><span style=\"font-size:12pt;\">Pituitary dysfunction</span></p>"
        },
        {
          "id": 23180,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian dysfunction</span></p>"
        },
        {
          "id": 23181,
          "text": "<p><span style=\"font-size:12pt;\">First pregnancy</span></p>"
        },
        {
          "id": 23182,
          "text": "<p><span style=\"font-size:12pt;\">Uterine synechiae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A young female has history of a induced abortion at 11 weeks. She has had amenorrhea since then. Her FSH now is 6 mlU/ml. Which of the following can be a cause for her amenorrhea?&nbsp;(INICET MAY 2018)</span></p>",
      "unique_key": "Q4084365",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Uterine synechiae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a spontaneous abortion and subsequent dilation and curettage (D&amp;C) is typically due to intrauterine adhesions, also known as Asherman syndrome.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Uterine Synechiae (Asherman Syndrome):</strong> This condition involves the formation of scar tissue within the uterine cavity, leading to amenorrhea or menstrual abnormalities. It commonly occurs after uterine surgeries like D&amp;C.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Diagnosis:</strong> Hysteroscopy is the gold standard for diagnosing Asherman syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:</strong> Hysteroscopic adhesiolysis is the treatment to remove the adhesions and restore normal uterine cavity function.</span></li></ul></li></ul><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pituitary dysfunction:</strong> This would typically be associated with abnormal levels of pituitary hormones, including FSH. The normal FSH level (6 mIU/ml) suggests that pituitary function is intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ovarian dysfunction:</strong> This condition would generally present with elevated or depressed levels of FSH and other ovarian hormones. The normal FSH level suggests that ovarian function is likely normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. First pregnancy:</strong> In pregnancy, FSH levels are very low (&lt;0.1 mIU/ml). The FSH level of 6 mIU/ml makes this an unlikely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a history of spontaneous abortion and D&amp;C is usually due to intrauterine adhesions (Asherman syndrome), diagnosed by hysteroscopy and treated with hysteroscopic adhesiolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 459, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49030,
      "choices": [
        {
          "id": 195695,
          "text": "<p><span style=\"font-size:18px;\">Slight</span></p>"
        },
        {
          "id": 195696,
          "text": "<p><span style=\"font-size:18px;\">Fair</span></p>"
        },
        {
          "id": 195697,
          "text": "<p><span style=\"font-size:18px;\">Moderate</span></p>"
        },
        {
          "id": 195698,
          "text": "<p><span style=\"font-size:18px;\">Substantial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>In a study involving radiographic evaluations, two physicians independently assessed 100 chest X-rays. They calculated a Kappa statistic of 0.71 to measure inter-rater agreement. What does this Kappa value indicate about the level of agreement between the two doctors? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q9403775",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618582,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Substantial</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Kappa statistic is used to measure the degree of agreement between two raters beyond what would be expected by chance. Here's what each value typically indicates about the level of agreement:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>A. Slight</strong>: A Kappa value from 0.01 to 0.20. This range indicates that there is minimal agreement between the two raters, barely above what would be expected by random chance.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>B. Fair: </strong>A Kappa value from 0.21 to 0.40. This suggests there is some agreement between the raters, but it remains relatively low.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>C. Moderate:</strong> A Kappa value from 0.41 to 0.60. This level indicates a moderate amount of agreement, showing that the raters often agree on their assessments.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>D. Substantial:</strong> A Kappa value from 0.61 to 0.80. This indicates a high level of agreement, suggesting that the raters consistently agree in their assessments most of the time.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>E. Near Perfect agreement</strong> – kappa value from 0.81 to 0.99</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>F. Perfect agreement</strong> – Kappa value – 1.00</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In this&nbsp; case, a Kappa value of 0.71 falls within the \"Substantial\" category, indicating a strong and consistent level of agreement between the two physicians assessing the chest X-rays. This is generally considered an excellent result in clinical settings, as it shows that both observers have a similar interpretation of the radiographic images, which can greatly improve diagnostic accuracy and patient care.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Kappa statistic is a reliable tool for assessing the consistency and reliability of diagnostic interpretations between different raters, especially in medical imaging where subjective judgment can vary.</span></li><li><span style=\"font-size:18px;\">High Kappa values, like 0.71, reinforce the reliability of the assessments and the potential for standardized approaches in clinical practice</span></li></ul>",
      "correct_choice_id": 195698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7044,
      "choices": [
        {
          "id": 28144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
        },
        {
          "id": 28145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifapentin</span></span></span></p>"
        },
        {
          "id": 28146,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone</span></span></span></p>"
        },
        {
          "id": 28147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanamycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-tubercular drug is not bactericidal? (</span></span>INICET May 2020)</p>",
      "unique_key": "Q3921200",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Thioacetazone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug. Bacteriostatic drugs inhibit the growth and replication of bacteria, rather than killing them outright. Thioacetazone is less commonly used nowadays due to its side effects and the availability of more effective treatments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Isoniazid is a bactericidal drug against actively dividing Mycobacterium tuberculosis bacteria. It works by inhibiting the synthesis of mycolic acid, a critical component of the bacterial cell wall.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rifapentin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rifapentin is a bactericidal antibiotic and is a derivative of rifampicin. It works by inhibiting bacterial RNA synthesis and is used primarily in the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Kanamycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Kanamycin is an aminoglycoside antibiotic and is bactericidal. It works by inhibiting bacterial protein synthesis. It is used as a second-line drug for the treatment of multidrug-resistant tuberculosis (MDR-TB).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug, which means it inhibits bacterial growth rather than killing the bacteria outright. In contrast, isoniazid, rifapentin, and kanamycin are all bactericidal drugs used in the treatment of tuberculosis.</span></span></span></p>",
      "correct_choice_id": 28146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6481,
      "choices": [
        {
          "id": 25893,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PGF2&alpha;</span></span></span></p>"
        },
        {
          "id": 25894,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PGE1</span></span></span></p>"
        },
        {
          "id": 25895,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PGH2</span></span></span></p>"
        },
        {
          "id": 25896,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PGI2</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following helps in maintaining the patency of ductus arteriosus?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q2302292",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618584,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) PGE1</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PGE1 (prostaglandin E1) keeps the ductus arteriosus open (PDA). It is useful in maintaining the patency of the Ductus Arteriosus in term neonates who are awaiting surgical correction of underlying cyanotic congenital heart disease and having a duct dependent circulation. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. PGF2&alpha;:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PGF2&alpha; (prostaglandin F2&alpha;) is involved in various physiological functions, including uterine contractions, but does not play a role in maintaining the patency of the ductus arteriosus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. PGH2:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PGH2 (prostaglandin H2) is a precursor in the prostaglandin synthesis pathway but does not directly maintain the patency of the ductus arteriosus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. PGI2:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PGI2 (prostacyclin) is a potent vasodilator and inhibitor of platelet aggregation but is not specifically used to maintain the patency of the ductus arteriosus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PGE1 (prostaglandin E1) is used to maintain the patency of the ductus arteriosus in neonates with congenital heart defects that require an open ductus arteriosus for adequate oxygenation and circulation.</span></span></span></p>",
      "correct_choice_id": 25894,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61374,
      "choices": [
        {
          "id": 244773,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood</span></span></span></p>"
        },
        {
          "id": 244774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urine</span></span></span></p>"
        },
        {
          "id": 244775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Saliva</span></span></span></p>"
        },
        {
          "id": 244776,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebrospinal fluid (CSF)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A newborn admitted to the NICU presents with microcephaly and hepatomegaly. The baby was born at 37 weeks gestation with low birth weight. A CT scan of the head shows nodular periventricular calcifications. The neonate also exhibits jaundice and thrombocytopenia. Based on these findings, congenital cytomegalovirus (CMV) infection is suspected. To confirm the diagnosis, which of the following samples is the most appropriate for detecting the virus using PCR?</span></span></span></p>",
      "unique_key": "Q1448952",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618585,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Urine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urine is the preferred sample for detecting congenital CMV infection using PCR because it typically contains a high viral load, making it a reliable option for early diagnosis. CMV can be detected using PCR or culture methods, and samples such as urine, saliva, or blood can be used. However, urine is often considered the best sample due to its sensitivity and ease of collection in neonates.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features of Congenital CMV Infection Include:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microcephaly</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Periventricular calcifications</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatosplenomegaly</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Jaundice</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrauterine growth retardation (IUGR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chorioretinitis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sensorineural hearing loss (SNHL)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blueberry-muffin-like rash</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombocytopenia</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/picture5.jpg\" style=\"height:491px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Blood:</strong> Blood can be used but has a lower viral load compared to urine, making it less sensitive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Saliva:</strong> While saliva is another option, there is a risk of contamination from maternal CMV, which can cause false positives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D) Cerebrospinal fluid (CSF):</strong> CSF is used more for assessing CNS involvement and is not typically used for primary detection of CMV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urine is the most sensitive sample for detecting congenital CMV using PCR, making it the best option for early diagnosis in neonates. Early detection and management are crucial in reducing the risk of complications associated with CMV infection.</span></span></span></p>",
      "correct_choice_id": 244774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13085,
      "choices": [
        {
          "id": 52302,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyphema</span></p>"
        },
        {
          "id": 52303,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Aqueous flare</span></p>"
        },
        {
          "id": 52304,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Arlt line</span></p>"
        },
        {
          "id": 52305,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hypopyon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A farmer presents with pain and discharge in his left eye. He says that he sustained an injury caused by a leaf a few days back. What is the finding seen in the image? (</span>INICET Nov 2022)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture3_9GuvF0u.jpg\" alt=\"\" width=\"400\" height=\"285\"></span></p>",
      "unique_key": "Q5719224",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618806,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypopyon&nbsp;</strong></span><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The finding seen in the image is hypopyon.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hypopyon is an accumulation of inflammatory cells in the anterior chamber of the eye, typically seen in the lower part of the chamber as a whitish exudate.</span></li><li><span style=\"font-size:12.0pt;\">In fungal corneal ulcers, the hypopyon may not be sterile as the fungus can penetrate into the anterior chamber without causing a perforation.</span></li><li><span style=\"font-size:12.0pt;\">Hypopyon associated with anterior uveitis is immobile because of the high fibrin content in the exudate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Hyphema</strong> is a hemorrhage in the anterior chamber. It commonly occurs after a blunt ocular injury. The bleeding is from the iris root or ciliary body face. The blood settles inferiorly forming a fluid level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_Y2WCgfK.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Aqueous flare</strong> refers to the haziness of the normally clear fluid in the anterior chamber. It reflects the presence of protein due to the breakdown of the blood-aqueous barrier. The presence of flare indicates active inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Arlt line</strong> is the scarring on the conjunctiva in the area of sulcus subtarsalis. It can be a single line, irregularly shaped, or star-shaped. Common causes are trachoma, healed traumatic wounds, or surgical scars.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_eRZ1892.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hypopyon </strong>is points to severe intraocular inflammation needing prompt treatment to preserve eye function and prevent potential complications. The presence of hypopyon after an injury with organic material highly suggests a fungal etiology, requiring specific antifungal treatment alongside broad-spectrum antibacterial coverage.</span></p>",
      "correct_choice_id": 52305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14061,
      "choices": [
        {
          "id": 56205,
          "text": "<p><span style=\"font-size:12.0pt;\">Achalasia cardia</span></p>"
        },
        {
          "id": 56206,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma esophagus</span></p>"
        },
        {
          "id": 56207,
          "text": "<p><span style=\"font-size:12.0pt;\">Esophageal stricture</span></p>"
        },
        {
          "id": 56208,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic pyloric stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Heller's operation is performed for: (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q3907937",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618807,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Achalasia cardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common surgical procedure done for achalasia cardia is laparoscopic Heller myotomy in conjugation with partial fundoplication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heller's operation is most commonly performed to treat Achalasia cardia. Achalasia is a medical condition characterized by the failure of the lower esophageal sphincter (LES) to relax properly, leading to difficulty in swallowing and the accumulation of food in the esophagus. Heller myotomy involves cutting the muscles of the LES to alleviate the obstruction and improve the passage of food into the stomach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B</strong>. <strong>Carcinoma</strong> <strong>esophagus</strong>: Cancer of the esophagus is typically treated with other approaches such as surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C</strong>. <strong>Esophageal</strong> <strong>stricture</strong>: Esophageal stricture refers to the narrowing of the esophagus, often due to scar tissue formation. Treatment for esophageal strictures may involve dilation procedures or other surgical techniques depending on the underlying cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>Hypertrophic pyloric stenosis</strong>: Treatment for hypertrophic pyloric stenosis typically involves a surgical procedure called Ramsteads pyloromyotomy to alleviate the obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Achalasia cardia, commonly referred to as achalasia, is a medical condition that affects the esophagus, specifically the lower esophageal sphincter (LES) and the muscles of the esophageal wall. This condition is characterized by the following features:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Failure of LES Relaxation:&nbsp;</strong>In achalasia, the LES, a muscular ring that separates the esophagus from the stomach, does not relax properly during swallowing. Normally, the LES should relax to allow food and liquids to pass into the stomach, but in achalasia, this relaxation is impaired.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Incomplete Emptying of the Esophagus:&nbsp;</strong>Due to the dysfunctional LES, the esophagus is unable to empty food and liquids into the stomach efficiently. This leads to a gradual buildup of food and fluids in the esophagus, causing symptoms.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Difficulty in Swallowing:&nbsp;</strong>The most prominent symptom of achalasia is dysphagia, which is difficulty in swallowing. Patients often experience a sensation of food getting stuck in the chest while eating and may need to drink fluids or change their body position to help food pass into the stomach.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Regurgitation:&nbsp;</strong>As a result of the esophageal emptying problems, patients with achalasia may also experience regurgitation of undigested food, often occurring at night when lying down.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chest Pain:&nbsp;</strong>Some individuals with achalasia may experience chest pain or discomfort, often due to the accumulation of food and fluids in the esophagus.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Achalasia is typically diagnosed through tests such as esophageal manometry, which measures the pressure within the esophagus, and barium swallow studies, which show the narrowing of the esophagus and the delayed emptying of contrast material.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment options for achalasia include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Heller Myotomy:&nbsp;</strong>This surgical procedure involves cutting the muscles of the LES to allow for improved passage of food and liquids into the stomach. It is the primary surgical treatment for achalasia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pneumatic Dilation:&nbsp;</strong>In this non-surgical procedure, a balloon is inflated within the LES to stretch and disrupt the muscle fibers, making it easier for food to pass.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Botulinum Toxin Injection:&nbsp;</strong>Injecting botulinum toxin directly into the LES can help relax the muscle temporarily. However, this treatment may need to be repeated periodically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The choice of treatment depends on various factors, including the patient's age, overall health, and the severity of the condition. Effective management of achalasia can alleviate symptoms and improve the quality of life for individuals with this disorder.</span></p>",
      "correct_choice_id": 56205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10243,
      "choices": [
        {
          "id": 40938,
          "text": "<p><span style=\"font-size:12pt;\">Yellow fluorescence</span></p>"
        },
        {
          "id": 40939,
          "text": "<p><span style=\"font-size:12pt;\">Coral red fluorescence</span></p>"
        },
        {
          "id": 40940,
          "text": "<p><span style=\"font-size:12pt;\">Blue fluorescence</span></p>"
        },
        {
          "id": 40941,
          "text": "<p><span style=\"font-size:12pt;\">Green fluorescence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a diabetic patient, the following lesions are present in the armpit. What would be observed during a Wood's lamp examination?&nbsp;</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"\" width=\"300\" height=\"224\"></p>",
      "unique_key": "Q5268184",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618808,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coral red fluorescence.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical scenario of a <strong>diabetic patient</strong>, along with the observed <strong>hyperpigmented </strong>lesion in <strong>axilla</strong> strongly suggests e<strong>rythrasma</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Coral-red fluorescence under Wood's lamp examination&nbsp;</strong>is the characteristic finding in this disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"\" width=\"400\" height=\"224\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Erythrasma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a skin infection caused by <strong>Corynebacterium minutissimum</strong>. This condition is commonly seen in individuals with diabetes and weakened immune systems and is associated with factors such as <strong>obesity, excessive sweating, and poor hygiene.</strong></span></li><li><span style=\"font-size:12pt;\">The characteristic feature of erythrasma is the <strong>presence of hyperpigmented patches that are typically asymptomatic.</strong> These patches commonly appear in areas like the <strong>axilla, groin, intergluteal, and sub-mammary regions.</strong></span></li><li><span style=\"font-size:12pt;\">The <strong>coral pink fluorescence observed during Wood's lamp examination</strong> is a defining feature of erythrasma and is caused by <strong>coproporphyrin III</strong>, a pigment produced by the <strong>bacterium</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture21.jpg\" alt=\"\" width=\"300\" height=\"249\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Wood's lamp uses ultraviolet wavelength light at <strong>365nm (320-400nm)</strong> with a peak at 365nm. <strong>The filter of the Wood's lamp is composed of Barium silicate and 9% Nickel oxide.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Yellow fluorescence:&nbsp;</strong>Often seen with <strong>Pityriasis versicolor</strong>, which fluoresces yellow or apple green due to the presence of tryptophan metabolites produced by Malassezia species.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Blue fluorescence:&nbsp;</strong>Not commonly associated with bacterial or fungal infections of the skin but may appear in certain conditions unrelated to common skin infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Green fluorescence:&nbsp;</strong>Typically observed with <strong>Pseudomonas infections</strong> or some cases of <strong>Tinea capitis</strong> caused by fungi that produce substances that fluoresce green.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Table: Various diseases &amp; their colour on woods lamp examination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-175903.jpg\" alt=\"\" width=\"1000\" height=\"422\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture22.jpg\" alt=\"\" width=\"300\" height=\"211\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture23.jpg\" alt=\"\" width=\"400\" height=\"166\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-182645.png\" alt=\"\" width=\"500\" height=\"228\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The <strong>Wood's</strong> lamp uses <strong>UVA</strong> light with a wavelength of <strong>365nm</strong> (<strong>320</strong>-<strong>400</strong> nm) for the diagnosis of various skin conditions based on the <strong>fluorescence</strong> characteristics of the skin under this specific range of ultraviolet light.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4 page no 4.20</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology -9th Edition, Chapter 26 Page no 26.40</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Image source: </strong></span><a href=\"https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg\"><span style=\"font-size:12pt;\"><strong><u>https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg</u></strong></span></a></p>",
      "correct_choice_id": 40939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14553,
      "choices": [
        {
          "id": 58173,
          "text": "<p><span style=\"font-size:12.0pt;\">Putty kidney</span></p>"
        },
        {
          "id": 58174,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrocalcinosis</span></p>"
        },
        {
          "id": 58175,
          "text": "<p><span style=\"font-size:12.0pt;\">Staghorn calculus</span></p>"
        },
        {
          "id": 58176,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoas calcification</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 32-year-old female patient presents with lower abdominal pain, frequent urination, and signs of dehydration. Physical examination reveals abdominal tenderness, and urine analysis indicates sterile pyuria. An image is provided. What is the most likely condition?&nbsp;(NEET PG 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns9.jpg\" alt=\"\" width=\"200\" height=\"294\"></span></p>",
      "unique_key": "Q7764932",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618809,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Putty kidney</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given image finding of a putty kidney is suggestive of genitourinary tuberculosis (TB).</span></li><li><span style=\"font-size:12pt;\">Putty kidney is characterized by a homogenous and ground glass-like calcification of the kidney.</span></li><li><span style=\"font-size:12pt;\">Genitourinary TB is a cause of sterile pyuria and is always a secondary TB caused by dissemination through the bloodstream.</span></li><li><span style=\"font-size:12pt;\">Diagnosis is confirmed by a tuberculin test or acid-fast bacilli staining and culture of urine samples.</span></li><li><span style=\"font-size:12pt;\">CT urography is the preferred imaging modality for visualizing renal calcifications and assessing the various stages of renal TB.</span></li><li><span style=\"font-size:12pt;\">Treatment involves short-course therapy with antitubercular drugs and surgical intervention may be necessary, such as partial nephrectomy, nephrectomy, or reconstructive surgery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nephrocalcinosis:</strong> Is the deposition of calcium in the kidney parenchyma or tubules, seen in hypercalcemia conditions like hyperparathyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Staghorncalculus:</strong> Kidney stones are a type of large urinary calculus that takes up a large portion of the urinary collecting area in the kidney. They often present in only one kidney, but in up to 15% of cases, they form in both. They often form due to recurrent urinary tract infections (UTIs).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Psoas calcification:</strong> Refers to the calcification (formation of calcium deposits) in the psoas muscle, which is a large muscle in the lower back that plays a role in hip flexion and trunk stabilization. Psoas calcification is not directly related to kidney or urinary system conditions and may have other underlying causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Putty kidney is a radiographic finding associated with genitourinary tuberculosis, characterized by homogenous, ground glass-like calcifications in the kidney.</span></li><li><span style=\"font-size:12pt;\">&nbsp;This condition typically presents with symptoms such as sterile pyuria, and diagnosis is confirmed through specific TB testing and imaging modalities like CT urography.</span></li><li><span style=\"font-size:12pt;\">&nbsp;Treatment usually involves antitubercular drugs and may require surgical intervention.</span></li></ul>",
      "correct_choice_id": 58173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5990,
      "choices": [
        {
          "id": 23930,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luteal phase LH</span></span></span></p>"
        },
        {
          "id": 23931,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post luteal phase LH</span></span></span></p>"
        },
        {
          "id": 23932,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH in the follicular phase</span></span></span></p>"
        },
        {
          "id": 23933,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian hormone (AMH)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the best measures ovarian reserve?&nbsp;</span></span></span>(INICET NOV 2021)</p>",
      "unique_key": "Q7856557",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618810,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Anti-Mullerian hormone (AMH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian Hormone (AMH)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a glycoprotein secreted by the granulosa cells of pre-antral follicles. It is the best marker of ovarian reserve because it can be tested on any day of the cycle.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Values and Interpretation:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal value:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2-6.8 ng/mL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poor ovarian reserve:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &lt;1 ng/mL</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic Ovary Disease (PCOD) and Hyperstimulation Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &gt;10 ng/mL</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tests for ovarian reserve:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Measured in the early follicular phase (Day 2 or 3 of the menstrual cycle). High FSH means the ovarian reserve is getting depleted.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum estradiol values:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Measured on day 3 of the cycle. Serum estradiol &gt;75 pg/mL indicates ovarian hypofunction.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antral follicular count on ultrasound:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Counts less than 4-5 on days 2-5 denote poor response to hormones.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibin B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Values &lt;40 pg/mL indicate poor reserve.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Luteal phase LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Not a reliable measure of ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Post luteal phase LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Not a reliable measure of ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. FSH in the follicular phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While useful, it is less reliable than AMH for assessing ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Mullerian Hormone (AMH) is the best marker of ovarian reserve as it can be tested on any day of the menstrual cycle and provides a reliable measure of the ovarian reserve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6<sup>th</sup> edition Pg 528,529, William&rsquo;s textbook of gynecology 3<sup>rd</sup> edition pg435</span></strong></span></span></p>",
      "correct_choice_id": 23933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11153,
      "choices": [
        {
          "id": 44578,
          "text": "<p><span style=\"font-size:18px;\">No treatment</span></p>"
        },
        {
          "id": 44579,
          "text": "<p><span style=\"font-size:18px;\">2 doses of vaccine on Day 0 &amp; 3</span></p>"
        },
        {
          "id": 44580,
          "text": "<p><span style=\"font-size:18px;\">5 doses of vaccine with Immunoglobulin</span></p>"
        },
        {
          "id": 44581,
          "text": "<p><span style=\"font-size:18px;\">5 doses of vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 5-year-old boy, previously vaccinated against rabies a year ago, was bitten by his vaccinated family pet dog on the toe, resulting in a bleeding wound. What is the most appropriate next step in the management of this child? </strong><i><strong>[AIIMS NOV 2019]</strong></i></span></p>",
      "unique_key": "Q5225387",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618811,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 2 doses of vaccine on Day 0 &amp; 3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The patient should receive 2 doses of vaccine on days 0 &amp; 3 as he has already received a prior course of post-exposure prophylaxis (PEP) &gt; 3 months ago.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174245.jpg\" alt=\"\" width=\"1000\" height=\"512\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">For a previously vaccinated individual bitten by a potentially rabid animal, the appropriate post-exposure prophylaxis is to administer 2 booster doses of the rabies vaccine on days 0 and 3.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174320.jpg\" alt=\"\" width=\"1000\" height=\"442\"></span></p>",
      "correct_choice_id": 44579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6976,
      "choices": [
        {
          "id": 27872,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B and C</span></span></span></p>"
        },
        {
          "id": 27873,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and C only</span></span></span></p>"
        },
        {
          "id": 27874,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B only</span></span></span></p>"
        },
        {
          "id": 27875,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs are used for absence seizures? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Carbamazepine</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Valproate</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Ethosuximide</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Gabapentin</span></span></span></p>",
      "unique_key": "Q4915448",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618812,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. B and C only</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first line drugs for treatment of absence seizures are valproate and ethosuximide. Carbamazepine and phenytoin are contra-indicated in absence seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs Used in Absence Seizures</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethosuximide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is specific for absence seizures. It works by blocking T-type calcium channels in the thalamus, which are believed to play a role in the generation of absence seizures.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproic Acid (Valproate)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Valproate is effective in treating a wide range of seizure types, including absence seizures. It works by increasing GABA levels and blocking sodium and calcium channels. Valproate is also used for bipolar disorder and migraine prophylaxis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Carbamazepine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine is not used for absence seizures. In fact, it can exacerbate absence seizures. It is typically used for partial seizures and generalized tonic-clonic seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Gabapentin: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gabapentin is not effective for absence seizures. It is mainly used for neuropathic pain and as an adjunctive treatment for partial seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DRUGS USED IN ABSENCE SEIZURES</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154357.jpg\" style=\"height:412px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 27873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32070,
      "choices": [
        {
          "id": 128150,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucilage</span></p>"
        },
        {
          "id": 128151,
          "text": "<p><span style=\"font-size:12.0pt;\">Cellulose</span></p>"
        },
        {
          "id": 128152,
          "text": "<p><span style=\"font-size:12.0pt;\">Gums</span></p>"
        },
        {
          "id": 128153,
          "text": "<p><span style=\"font-size:12.0pt;\">Pectins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which absorbs least water?&nbsp;</span>(NEET PG 2020)</p>",
      "unique_key": "Q1021732",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Cellulose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cellulose is an insoluble fiber that does not absorb water to a significant extent. It remains relatively dry when exposed to water and does not become gummy. Cellulose is known for its role in providing structure to plant cell walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mucilage:&nbsp;</strong>Mucilage is a type of soluble fiber that absorbs water and becomes gummy when mixed with it. It has the capacity to absorb a significant amount of water and is often used in various applications due to its water-absorbing properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gums:&nbsp;</strong>Gums, such as guar gum and xanthan gum, are water-soluble fibers that can absorb water and form a gel-like consistency. They have the ability to absorb moderate amounts of water.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pectins:&nbsp;</strong>Pectins are another type of water-soluble fiber found in plant cells. When pectins come into contact with water, they form a gel-like substance and can absorb a considerable amount of water.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cellulose</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Most abundant natural polysaccharide</span></li><li><span style=\"font-size:12.0pt;\">Unbranched&nbsp;<strong> &nbsp;</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Made up of β–Glucose residues</span></li><li><span style=\"font-size:12.0pt;\">Acts as fibres in the diet (as β-bonds cannot be easily broken in body)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Lehninger 6<sup>th</sup> ed pg 257</strong></span></p>",
      "correct_choice_id": 128151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6843,
      "choices": [
        {
          "id": 27340,
          "text": "<p><span style=\"font-size:12.0pt;\">90 mmHg</span></p>"
        },
        {
          "id": 27341,
          "text": "<p><span style=\"font-size:12.0pt;\">60 mmHg</span></p>"
        },
        {
          "id": 27342,
          "text": "<p><span style=\"font-size:12.0pt;\">30 mmHg</span></p>"
        },
        {
          "id": 27343,
          "text": "<p><span style=\"font-size:12.0pt;\">15 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the net filtration pressure across the GFM for a patient with the data given below? (</span>AIIMS May 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glomerular ultrafiltration coefficient = 6</span></p><p><span style=\"font-size:12.0pt;\">Glomerular hydrostatic pressure =45</span></p><p><span style=\"font-size:12.0pt;\">Glomerular capillary oncotic pressure =20</span></p><p><span style=\"font-size:12.0pt;\">Bowman's capsule hydrostatic pressure =10</span></p><p><span style=\"font-size:12.0pt;\">Bowman's capsule oncotic pressure =0</span></p>",
      "unique_key": "Q2455940",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618814,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) 15 mmHg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Four primary forces that determine whether fluid will move out of the blood into the interstitial fluid or in the opposite direction. These forces are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">The <strong>capillary pressure (Pc),&nbsp;</strong>which tends to force fluid outward through the capillary membrane.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>interstitial fluid pressure (Pif),&nbsp;</strong>which tends to force fluid inward through the capillary membrane when Pif is positive but outward when Pif is negative.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>capillary plasma colloid osmotic pressure</strong> <strong>(Pp)</strong>, which tends to cause osmosis of fluid inward through the capillary membrane.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>interstitial fluid colloid osmotic pressure</strong> <strong>(Cif),&nbsp;</strong>which tends to cause osmosis of fluid outward through the capillary membrane.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the sum of these forces, the net filtration pressure, is positive, there will be a net fluid filtration across the capillaries. If the sum of the Starling forces is negative, there will be a net fluid absorption from the interstitial spaces into the capillaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The net filtration pressure (NFP) is calculated as:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NFP = Pc - Pif - Pp + Cif</span></p><p><br><span style=\"font-size:12.0pt;\">Where Pc – Capillary pressure, Pif is Interstitial fluid pressure, Pp is plasma colloid osmotic pressure, Cif is interstitial colloid osmotic pressure</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, Net filtration pressure = 45 – 10 – 20 + 0 = 15mmHg</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">The net filtration pressure (NFP) in the glomerulus, essential for kidney filtration, is calculated based on the differences between hydrostatic and oncotic pressures inside and outside the glomerular capillaries. In this scenario, an NFP of 15 mmHg favors the formation of urine by pushing fluid out of blood vessels into the Bowman's capsule.</span></p>",
      "correct_choice_id": 27343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61373,
      "choices": [
        {
          "id": 244769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Structure 1</span></span></span></p>"
        },
        {
          "id": 244770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Structure 2</span></span></span></p>"
        },
        {
          "id": 244771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Structure 3</span></span></span></p>"
        },
        {
          "id": 244772,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A preterm infant is experiencing severe respiratory distress shortly after birth, characterized by tachypnea, nasal flaring, and cyanosis. A chest X-ray reveals diffuse ground-glass opacities consistent with a diagnosis of respiratory distress syndrome (RDS). Surfactant deficiency is suspected as a contributing factor. Which of the following marked structures in the image is primarily involved in this condition?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/picture2_Ae7VSRg.jpg\" style=\"height:276px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2343600",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618815,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Structure 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type II pneumocytes, represented by Structure 2 in the image, are essential cells in the alveoli responsible for producing surfactant, a crucial substance that reduces surface tension within the alveoli and prevents their collapse during exhalation. These cells also play a significant role in alveolar repair by differentiating into type I pneumocytes when necessary. In respiratory distress syndrome (RDS), especially in premature infants, the type II pneumocytes are either immature or dysfunctional, leading to inadequate surfactant production. This deficiency results in increased surface tension, alveolar collapse, impaired gas exchange, and the characteristic respiratory distress seen in RDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/picture3_N7h5EYx.jpg\" style=\"height:329px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Structure</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> 1 (Type I pneumocytes):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These cells form the primary lining of the alveoli, providing a thin barrier for gas exchange but do not produce surfactant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Structure</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> 3 (Capillary endothelial cells):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These cells line the blood vessels within the alveolar walls and are involved in gas exchange but are not involved in surfactant production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) Structure 4 (Macrophages</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These immune cells are responsible for removing debris and pathogens from the alveoli but do not play a direct role in surfactant production or the pathophysiology of RDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II pneumocytes produce surfactant, which is crucial in maintaining alveolar stability by reducing surface tension. In conditions like respiratory distress syndrome, damage or dysfunction of type II pneumocytes leads to surfactant deficiency, resulting in alveolar collapse, impaired gas exchange, and respiratory failure.</span></span></p>",
      "correct_choice_id": 244770,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10074,
      "choices": [
        {
          "id": 40262,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha defensins</span></p>"
        },
        {
          "id": 40263,
          "text": "<p><span style=\"font-size:12.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 40264,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma Delta T lymphocytes</span></p>"
        },
        {
          "id": 40265,
          "text": "<p><span style=\"font-size:12.0pt;\">Lectin pathway</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are the part of the innate immunity except:&nbsp;(INICET MAY 2022)</span></p>",
      "unique_key": "Q4532599",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618816,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) B lymphocytes</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-121910.jpg\" alt=\"\" width=\"1000\" height=\"388\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Alpha defensins</strong>: These are antimicrobial peptides that are part of the innate immune system. They are produced by neutrophils and epithelial cells and help to protect against a wide range of pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Gamma Delta T lymphocytes</strong>: These are a subset of T cells that participate in both the innate and adaptive immune responses. They are considered part of the innate immune system due to their ability to respond quickly and non-specifically to a wide range of pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Lectin pathway</strong>: The lectin pathway is one of the pathways that activate the complement system, a key component of innate immunity. It is initiated by the binding of mannose-binding lectin (MBL) to pathogen surfaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-122406.jpg\" alt=\"\" width=\"1000\" height=\"445\"></p>",
      "correct_choice_id": 40263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6983,
      "choices": [
        {
          "id": 27900,
          "text": "<p><span style=\"font-size:12.0pt;\">Influx of Na<sup>+</sup></span></p>"
        },
        {
          "id": 27901,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Efflux of Na<sup>+</sup></span></p>"
        },
        {
          "id": 27902,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Influx of K<sup>+</sup></span></p>"
        },
        {
          "id": 27903,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Efflux of K<sup>+</sup></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image shows changes in membrane potential during an action potential. The region marked between 4 to 5 is due to?</span>(INICET NOV 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-982_1Mke7Lg.jpg\" alt=\"\" width=\"500\" height=\"316\"></p>",
      "unique_key": "Q6035357",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618817,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Efflux of K<sup>+</sup></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The action potential curve shows the different phases of an action potential in a neuron. The region marked between 4 and 5 corresponds to repolarization and hyperpolarization.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Phase 4 to 5 (Repolarization and Hyperpolarization):</strong> During this phase, voltage-gated potassium channels remain open, and there is an efflux of K+ ions from the cell, causing the membrane potential to return to the resting level or even become more negative (hyperpolarization).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Influx of Na+</strong>: This occurs during the depolarization phase (Phase 0 to 1), not during repolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Efflux of Na+</strong>: This does not occur in the action potential phases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Influx of K+</strong>: Potassium ions typically move out of the cell (efflux) during repolarization, not into the cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-983.jpg\" alt=\"\" width=\"700\" height=\"585\"></p>",
      "correct_choice_id": 27903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6155,
      "choices": [
        {
          "id": 24589,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 24590,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomania</span></p>"
        },
        {
          "id": 24591,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclothymia</span></p>"
        },
        {
          "id": 24592,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizomania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presented with overfamiliarity, flight of ideas, elevated mood, increased sexual desire, and pseudo hallucination. What is the likely diagnosis?&nbsp;</span>(NEET PG 2021)</p>",
      "unique_key": "Q8373146",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618818,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mania</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of overfamiliarity, flight of ideas, elevated mood, increased sexual desire, and pseudo hallucination are indicative of a manic episode. Mania is characterized by an elevated, expansive, or irritable mood, lasting at least one week, associated with increased energy or activity, and causing significant impairment in social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypomania:</strong> Similar to mania but the symptoms are milder, last for at least 4 days, and don't significantly impair social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Cyclothymia:</strong> A mood disorder characterized by periods of hypomanic symptoms and periods of depressive symptoms that don't meet the full criteria for a manic or major depressive episode.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Schizomania:</strong> This term is not standard in psychiatric diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mania is characterized by an elevated, expansive, or irritable mood, lasting at least one week, associated with increased energy or activity, and causing significant impairment in social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan and Sadock’s Synopsis of Psychiatry, 12th edition, Page No 365</strong></span></p>",
      "correct_choice_id": 24589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9939,
      "choices": [
        {
          "id": 39722,
          "text": "<p><span style=\"font-size:12.0pt;\">Tubulo-villous adenoma</span></p>"
        },
        {
          "id": 39723,
          "text": "<p><span style=\"font-size:12.0pt;\">Hamartomatous polyp</span></p>"
        },
        {
          "id": 39724,
          "text": "<p><span style=\"font-size:12.0pt;\">Villous Adenoma</span></p>"
        },
        {
          "id": 39725,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperplastic polyp</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy was diagnosed with intussusception and is taken up for surgery. The surgeon found multiple polyps and sent the resected section for histopathology. The image is given below. What is the type of lesion?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/13.jpg\" alt=\"\" width=\"300\" height=\"237\"></span></p>",
      "unique_key": "Q9860277",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618819,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) Hamartomatous polyp</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image and clinical scenario point towards a <strong>hamartomatous polyp</strong>, particularly because of the patient's young age and the finding of multiple polyps. Hamartomatous polyps are generally solitary lesions but can be multiple in certain syndromes, such as <strong>Peutz-Jeghers syndrome</strong> and <strong>juvenile polyposis syndrome</strong>, which are more common in children and adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hamartomatous polyps are benign, disorganized growths of tissue that are normally found in the location where they arise. In the context of Peutz-Jeghers syndrome, these polyps are associated with an increased risk of intussusception due to their size and location in the gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tubulo-villous adenoma</strong>: This type of adenoma has both tubular and villous features and is typically found in older adults, with a higher risk of malignant transformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Villous Adenoma</strong>: These are the most dangerous types of adenomas due to their higher potential for malignancy, but they are usually seen in older patients and have a distinctive villous histological appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperplastic polyp</strong>: Generally benign and more common in adults, hyperplastic polyps are typically located in the distal colon and rectum and are not associated with intussusception or multiple polyps in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-181904.jpg\" alt=\"\" width=\"1000\" height=\"769\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans pathologic basis of disease 8th edition pg 1557</strong></span></p>",
      "correct_choice_id": 39723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5854,
      "choices": [
        {
          "id": 23386,
          "text": "<p><span style=\"font-size:12pt;\">Gardasil</span></p>"
        },
        {
          "id": 23387,
          "text": "<p><span style=\"font-size:12pt;\">Biovac</span></p>"
        },
        {
          "id": 23388,
          "text": "<p><span style=\"font-size:12pt;\">Rabivac</span></p>"
        },
        {
          "id": 23389,
          "text": "<p><span style=\"font-size:12pt;\">Tvac</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old unmarried female has come to the gynae OPD for cervical cancer vaccination. Which is preferred?</span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q3408412",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618820,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gardasil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for cervical cancer prevention. It is a quadrivalent HPV vaccine that provides protection against four serotypes of the Human Papillomavirus (HPV): 6, 11, 16, and 18.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>HPV Serotypes Covered by Gardasil:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>6 and 11:</strong> These types are associated with anogenital warts.</span></li><li><span style=\"font-size:12pt;\"><strong>16 and 18:</strong> These types are linked to cervical cancer and other HPV-related cancers.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is administered as an intramuscular injection with a recommended schedule of three doses (0, 2, and 6 months).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Available HPV Vaccines:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Cervarix (Bivalent):</strong> Covers HPV serotypes 16 and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil (Quadrivalent):</strong> Covers HPV serotypes 6, 11, 16, and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil 9 (Nonavalent or HPV9):</strong> Covers HPV serotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervavac (India’s indigenous HPV vaccine):</strong> Quadrivalent, covers serotypes 6, 11, 16, and 18.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Biovac:</strong> This is a vaccine for Hepatitis A, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rabivac:</strong> This is a rabies vaccine for animals, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tvac:</strong> This is a tetanus vaccine, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for preventing cervical cancer and related HPV diseases, covering serotypes 6, 11, 16, and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)</u></strong></span></a></p>",
      "correct_choice_id": 23386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2889,
      "choices": [
        {
          "id": 11541,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrophoresis</span></p>"
        },
        {
          "id": 11542,
          "text": "<p><span style=\"font-size:12.0pt;\">Ion-exchange chromatography</span></p>"
        },
        {
          "id": 11543,
          "text": "<p><span style=\"font-size:12.0pt;\">Affinity chromatography</span></p>"
        },
        {
          "id": 11544,
          "text": "<p><span style=\"font-size:12.0pt;\">Immuno turbidimetry</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most preferred chromatography for HbA1c? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q1825118",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618821,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ion-exchange chromatography</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Ion-exchange chromatography is the most preferred method for HbA1c analysis that separates molecules based on their charge.</span></li><li><span style=\"font-size:12.0pt;\">While it can be used for HbA1c analysis,</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Electrophoresis:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Electrophoresis is a technique that separates molecules based on their charge and size.</span></li><li><span style=\"font-size:12.0pt;\">It is not the most preferred method for HbA1c analysis because it may not provide the specificity and accuracy needed for precise quantification of glycated hemoglobin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Affinity chromatography:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Affinity chromatography separates glycated hemoglobin based on its specific affinity for a stationary phase that can selectively bind to HbA1c.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Immuno turbidimetry:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Immuno turbidimetry is a technique that measures the concentration of substances in a solution based on the degree of turbidity.</span></li><li><span style=\"font-size:12.0pt;\">While it can be used for HbA1c analysis, it may not be as specific as affinity chromatography.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glycated hemoglobin (GHB), reported as hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>), is a biochemical marker that is used routinely in the management of individuals with diabetes mellitus to <strong>monitor long-term glycemic control and assess the risk of developing complications.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Four basic types of methods are used most commonly to measure HbA1c: immunoassay, ion-exchange high-performance liquid chromatography (HPLC), boronate affinity HPLC, and enzymatic assays.</span></p>",
      "correct_choice_id": 11542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4253,
      "choices": [
        {
          "id": 16989,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3 and 4</span></span></span></p>"
        },
        {
          "id": 16990,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2 and 4</span></span></span></p>"
        },
        {
          "id": 16991,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3 and 4</span></span></span></p>"
        },
        {
          "id": 16992,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3 and 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following method of disinfection and sterilization can also kill spores?</span> (<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutaraldehyde</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethylene oxide</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pasteurization</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ortho-phthalaldehyde</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9405645",
      "question_audio": null,
      "question_video": null,
      "map_id": 13618842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2 and 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutaraldehyde, Ethylene oxide, and Ortho-phthalaldehyde are effective methods of disinfection and sterilization that can kill spores.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Glutaraldehyde</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This chemical is a broad-spectrum microbicidal and sporicidal agent. It is known for its compatibility with a variety of medical instruments. However, it requires activation and produces irritant fumes, which are notable disadvantages. Despite these drawbacks, glutaraldehyde is commonly recommended for the disinfection of fibroscopes and respiratory equipment due to its efficacy against spores and other microorganisms.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. ETO (Ethylene oxide)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> inactivates all microorganisms although bacterial spores (especially B. atrophaeus) are more resistant than other microorganisms. For this reason B. atrophaeus is the recommended biological indicator. ETO is used in healthcare facilities to sterilize critical items (and sometimes semicritical items) that are moisture or heat sensitive and cannot be sterilized by steam sterilization like syringes, needles, catheters, and gloves. Bacillus atrophaeus and Bacillus subtilis are used as sterilization control.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Ortho-phthalaldehyde</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Similar to glutaraldehyde, ortho-phthalaldehyde is a broad-spectrum microbicidal and sporicidal agent. It does not require activation and does not produce irritating fumes, which are significant advantages. However, it is costly and can stain medical equipment. It is often used as an alternative to glutaraldehyde for disinfecting scopes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Pasteurization</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> or pasteurization is a process of food preservation in which packaged and non-packaged foods (such as milk and fruit juices) are treated with mild heat, usually to less than 100 &deg;C (212 &deg;F), to eliminate pathogens and extend shelf life. It has no sporicidal activity and kills non-spore-forming bacteria like Mycobacteria, Brucella, and Salmonella. There are two methods-</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Holder method -&nbsp; milk is heated at either 63&deg;C for 30 minutes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. Coxiella burnetii is relatively heat resistant and may survive the holder method.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flash method - milk is heated at 72&deg;C for 15-20 seconds</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> followed by cooling quickly to 13&deg;C or lower. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-111846.png\" style=\"height:1047px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 16990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}